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ABSTRACT 
BACKGROUD. Dietary proteins are the source of the amino acids required by the 
body for tissue growth and maintenance. The Population Reference Intake (PRI) for 
proteins, as defined by the European Food Safety Authority (EFSA) for healthy adults, 
including the elderly, is 0.83 g/kg body weight/day. This amount is defined on the net 
balance of body protein (or “nitrogen balance”, given by the difference between dietary 
nitrogen intake and losses) equivalent to 0.66 g/kg/day plus a safety factor for 
interpersonal variability and differences in proteins quality of mixed diets. The PRI, 
however, is the minimum daily amount of protein needed to maintain the nitrogen 
balance and avoid a progressive loss of lean body mass in healthy people with moderate 
physical activity. Therefore nitrogen balance may not be adequate to define protein 
requirement in adults and especially in ageing characterized by loss of muscle mass and 
function (sarcopenia). Furthermore until recently the prevalent idea was that a protein 
intake above PRI had no further benefits and on the contrary could impair health. These 
believes are now under discussion, diets with higher protein intake have been shown 
beneficial in the prevention and treatment of conditions such as sarcopenia, COPD and 
type 2 diabetes mellitus. There is a need of more precise methods to define protein 
requirement. 
AIM. The aim of the present thesis is to investigate in human healthy volunteers new 
biomarkers adequate to define optimal protein intake. Recent studies have determined 
protein needs by measuring whole-body protein metabolism using stable labeled 
isotope-amino acids.  
METHODS. Our research group has applied two different metabolic methods based on 
the most widely used tracer, i.e. D5-Phe stable isotope, in two experimental bed rest 
campaigns (FP7 PLANHAB and INTERREG PANGaA) in healthy volunteers. BR is a 
suitable model to investigate physiologic adaptation to inactivity. 
MAIN RESUTLTS. FP7 PLANHAB. We applied the stable isotope infusion 
technique, to assess the effect of physical inactivity and/or hypoxic condition on whole 
body protein turnover as previously described in Biolo et al 2008. Chronic hypoxia has 
been associated with an overall reduction in protein synthesis and in total plasma and 
skeletal muscle protein content. During the PLANHAB study we investigated, through 
a crossover randomization, the net effects of 10 days normobaric hypoxia (4000 mt.), 
associated with either ambulatory conditions or BR, in 11 young (age 24±4 yr), healthy 
and normal weight male subjects maintained on eucaloric diets. Main results. Hypoxia 
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in ambulatory conditions significantly decreased whole body protein turnover by 
reducing both protein synthesis (-8±2%) and protein degradation (-8±3%). Hypoxia 
during bed rest did not caused significant changes in protein metabolism. 
INTERREG PANGaA. The skeletal muscle loss in aging is caused mainly by the 
“anabolic resistance” i.e. the inadequate increase in the rate of protein synthesis in 
response to nutritional-metabolic stimuli, including exercise, protein and amino acid 
intake as well as insulin and insulin-like growth factor stimulation. As a consequence, 
the net protein balance becomes negative leading to sarcopenia. The effects of ageing 
on the anabolic resistance induced by inactivity are poorly investigated. During the 
PANGeA study we had the opportunity to perform the second documented 
experimental BR in in healthy elderly volunteers and the first comparing aged with 
young subjects. To evaluate the anabolic resistance associated with ageing and 
inactivity, we enrolled 7 young (23±1yr) and 8 elderly (59±1yr) normal weight 
individuals, in a 14-d experimental BR protocol. We replaced our previous infusion 
method with a new, simpler, safer and quicker technique, by which tracers are given 
orally instead of parenterally, the all procedure is completed in two hours, instead of 6, 
and only two blood draws versus 7 are sufficient. Main results. At baseline parameters 
of anabolic sensitivity were comparable between young and elderly individuals. The 
anabolic resistance significantly increased after BR in both groups (bed-rest effect 
p<0.01), with a statistically significant bed-rest×group interaction (p=0.01). Anabolic 
resistance increased significantly in elderly (18.5%±7.3%) more than in young 
(5.2%±9.4%) subjects. 
DISCUSSION. In the PLANHAB study, hypoxia in ambulatory conditions reduced by 
the same level both protein synthesis and catabolism, as measured by isotope infusions, 
suggesting an adaptive mechanism: the lower energy production and availability 
induced by hypoxia associated with ambulatory condition. These modifications could 
not have been revealed by the use of nitrogen balance method, showing the relevance of 
more sophisticated analysis. The direct evaluation of the muscle protein metabolism 
through an infusion of stable-labeled isotope tracer, considered the golden standard 
methodology, gave us, in the PLANHAB study, reliable results in the early protein 
metabolism changes during hypoxia and/or BR. This method however has the limit of 
being complex, onerous and invasive, therefore being unsuitable for clinical evaluation. 
In the PANGeA study we could confirm the presence of a reduced sensitivity to 
anabolic stimuli in the elderly population compared to the young men. The elderly 
subjects are therefore, more at risk to develop changes of protein metabolism induced 
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by inactivity. The simpler, timesaving and less invasive method we have developed for 
the PANGeA study, on the other hand, could be applied to a wider ranges of 
experimental conditions and clinical settings. 
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1. INTRODUCTION 
1.1. Protein composition and metabolism 
Proteins are the major nitrogen components of the protoplasm of animal tissue, 
representing 50% of the dry weight of animal cells. They are formed by a sequence of 
amino acids (AA), the basic structural units, attached by covalent chemical bonds (i.e. 
peptide bond). AA are characterized by the presence of both a carboxyl group (R-
COOH) and an amino group (R-NH3), nitrogen being equivalent to about 16% of 
protein weight (Shils ME et al. 2006; Caballero B et al. 2012). There are 20 different 
AAs commonly classified in essentials, EAA (or indispensable), which, since their 
carbon skeleton cannot be synthetized by the animal body, need to be introduced by 
diet, and non-essentials, NEAA (or dispensable), made in the body from carbon and 
nitrogen precursors. In humans the EAA include: histidine, valine, isoleucine, leucine, 
lysine, methionine, phenylalanine, threonine, tryptophan, and possibly arginine, while 
the NEAAs are reported on figure 1. Cysteine and tyrosine are synthesized in the body 
from the EAAs methionine and phenylalanine. AAs are further divided in: dibasic 
(arginine lysine and histidine), diacidic (aspartic, glutamic acid), neutral-aliphatic 
(glycine, alanine, serine, threonine, cysteine, cystine, methionine and the three 
branched-chain AAs -BCAA- valine, leucine, isoleucine) and neutral-aromatic 
(phenylalanine, tyrosine and tryptophan). In the human body proteins have multiple 
roles. From structural to regulatory (e.g. hormonal activities) to functional (e.g. 
enzymes, muscle contraction, transport, osmolality regulation, etc.) (Shils ME et al. 
2006; Caballero B et al. 2012). 
Proteins, consumed with the diet are enzymatically hydrolyzed in the digestive system 
and them reach the peripheral circulation as free amino acids. These AAs mix with 
those coming from the tissues protein catabolism forming the circulating free AA pool. 
Amino acids follow one of the follow three major metabolic ways: a) incorporation into 
tissue proteins (protein synthesis); b) catabolism by oxidation and nitrogen excretion; c) 
synthesis of other nitrogen compounds, including purine bases, creatine and 
epinephrine. The absorbed AAs through the vena porta reach the liver, where, with the 
exclusion of the BCAAs, are catabolized at a rate influenced by the body requirements; 
therefore when EAA intake is elevated, their catabolism is also increased. Through this 
mechanism the liver regulates the amount of EAA obtained from the diet, which will be 
available to the rest of the body. A small portion of the absorbed EAAs is used for the 
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synthesis of liver proteins and of visceral plasma proteins, secreted by the liver, 
including albumin, transferrin, pre-albumin, etc. Finally, about one quarter of the diet 
EAAs reach the general circulation. The BCAAs from the liver are transported to other 
tissues, being metabolized mainly by muscle and kidney. On the other hand, NEAA 
plasma concentration is not modified by the passage through the liver. The metabolic 
pathways of NEAAs are showed in figure 1 (Shils ME et al. 2006; Caballero B et al. 
2012). 
 
Figure 1. Metabolic pathways of the dispensable amino acids. 
From Shils ME et al. 2006.  
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Skeletal muscle is the major body site of protein metabolism, being the largest tissue in 
the body (Shils ME et al. 2006; Caballero B et al. 2012). Muscle protein synthesis 
(MPS) is influenced by AA availability after the intake of a meal containing proteins. 
The post-prandial anabolic response is followed in the post-absorptive period, by a 
catabolic phase (i.e. muscle protein breakdown, MPB) (Figure 2), the magnitude of 
these metabolic cycles being influenced by the quantity and quality of protein intake 
and the meal nutrient composition and pattern. During fasting the muscles release AAs, 
mainly as alanine and glutamine (with a daily loss equivalent to about 50g of protein in 
an 70kg individual) (Shils ME et al. 2006; Caballero B et al. 2012). Alanine is derived 
by transamination between pyruvate from glucose, and the amino-groups of AAs 
originating from MPB. Alanine carries nitrogen to the liver where gluconeogenesis 
takes place. Glucose is formed from the carbon skeleton of alanine, while the amino-
group is either converted to urea or transaminated. Glutamine, formed in skeletal 
muscle by transamination with glutamate, is transported to the intestine, where 50% 
gets transaminated to alanine, thereafter carried to the liver for gluconeogenesis and 
urea synthesis (Shils ME et al. 2006; Caballero B et al. 2012). Part of the glucose 
produced by gluconeogenesis in the liver returns to the muscles, the all process being 
called “glucose-alanine cycle” (Figure 2B).  
 
 
 
Figure 2. Substrate interorgan flow in the post-absorptive state (A) and in 
starvation (B).  
From Shils ME et al. 2006. 
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Fig. 1.13. Interorgan flow of substrates in the body to maintain energy balance in the postabsorptive state (A) and after adaptation to starvation 
(B). The schematic diagrams are patterned after the work of Cahill. In all states, energy needs of the brain must be satisfied. In the postabsorp-
tive state, glucose from liver glycogenolysis provides the majority of the glucose needed by the brain. After liver glycogen stores have been 
depleted (fasting state), gluconeogenesis from amino acids from muscle stores predominates as the glucose source. Eventually, the body adapts 
to  starvation by production and utilization of ketone bodies instead of glucose, thereby sparing amino acid loss for gluconeogenesis. AA’s, amino 
acids; Ala,  alanine; CO2, carbon dioxide; FFA, free fatty acids; Gln, glutamine; O2, oxygen; TG, triglycerides. (Redrawn with permission from Cahill 
GF Jr, Aoki TT. Partial and total starvation. In: Kinney JM, ed. Assessment of Energy Metabolism in Health and Disease. Report of the First Ross 
Conference on Medical Research. Columbus, OH: Ross Laboratories, 1980:129–34.)
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previously for those amino acids for which their carbon 
skeletons can be easily rearranged to form gluconeogenic 
precursors. The remaining amino acids released from 
protein breakdown and not used for gluconeogenesis may 
be oxidized. The amino acid N released by this process 
is removed from the body by incorporation into urea via 
synthesis in the liver and excretion into urine via the kid-
ney. Gluconeogenesis also occurs in the kidney, but the 
effect and magnitude are masked from AV measurements 
because the kidney is also a glucose consumer (112, 113).
Role of Skeletal Muscle in Whole Body 
Amino Acid Metabolism
An interesting observation from the early AV difference 
studies across the human leg and arm was that more than 
50% of the amino acids released from skeletal muscle was 
in the form of alanine and glutamine (114), yet alanine 
and glutamine comprise less than 20% of amino acids in 
protein (see Table 1.3). Several possible reasons exist for 
the release of alanine and glutamine from muscle in such 
large amounts. First, skeletal muscle oxidizes dispensable 
amino acids and the BCAAs in situ for energy. Because 
amino acid oxidation produces waste N and because 
NH3 is neurotoxic, release of waste N as NH3 must be 
avoided. Given that both alanine and glutamine are  readily 
synthesized from intermediates derived from glucose 
(alanine from transamination of pyruvate from glycolysis, 
and glutamine from a-ketoglutarate), they are excellent 
vehicles to remove waste N from muscle while avoiding 
NH3 release. Alanine removes one and glutamine removes 
two Ns per amino acid. These observations led to the pro-
posal of a glucose-alanine cycle in which glucose made by 
the liver is taken up by muscle where glycolysis liberates 
pyruvate. The pyruvate is then transaminated to alanine 
and is released from muscle. That alanine is extracted by 
the liver and is transaminated to pyruvate, which is then 
used for glucose synthesis (114). This scheme has been 
expanded to explain the utilization of BCAAs by muscle 
for energy and disposal through alanine of their amino-N 
groups. Such a scheme resolves a problem related to the 
BCAAs. In contrast to the other IDAAs that are metabo-
lized only in liver, the BCAAs are readily oxidized in other 
tissues, especially muscle.
Metabolic Adaptation to Fasting and Starvation
As indicated in Figure 1.13A, lipolysis (breakdown of 
adipose triglyceride to free fatty acids and glycerol) plays 
a lesser role in postabsorptive energy supply, especially 
to the brain. Glycogen stores are limited, however, and 
become depleted in less than 24 hours. That point in time 
when liver glycogen stores are exhausted is by definition 
the beginning of the fasting state. Now glucose needs of 
the brain must be met completely by gluconeogenesis, 
which means sacrificing amino acids from protein. Because 
MNHD11e_CH001.indd   25 09/24/12   5:00 PM
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The plasma levels of amino acids are also affected by dietary carbohydrate through a 
mechanism involving insulin secretion. After digestion of dietary carbohydrates and 
monosaccharaides absorption, the raising plasma glucose concentration stimulates 
insulin secretion, favoring an increased insulin-mediated transport of most plasma 
amino acids into the muscle cells (Caballero B et al. 2012). This effect is maximal for 
BCAAs, whose plasma levels can fall as much as 40% after glucose intake (Caballero B 
et al. 2012). 
When amino acids are degraded for energy rather than entering in anabolic pathways, 
the ultimate products are CO2 and water, produced through the pathways of 
intermediary metabolism involving the tricarboxylic acid cycle, and urea, whose 
synthesis allows the removal of toxic metabolites, such as ammonia (Shils ME et al. 
2006; Caballero B et al. 2012). 
The whole body protein turnover is the result of protein synthesis and breakdown 
processes (Antonione R et al. 2008). 
1.1.1. Protein synthesis 
At the molecular level, regulation of protein synthesis depends both on transcriptional 
and translational mechanisms. The concentration of ribosomes in tissues determines the 
capacity for protein synthesis, therefore controlling the protein turnover rate. The 
concentration of ribosome, inside the cells is influenced by nutrient intake (protein and 
energy) and hormones (i.e. insulin, thyroid, growth hormone and glucocorticoids). The 
regulation of the translational processes is exerted mainly through initiation, with 
reversible phosphorylations known to control at least four separate steps of the initiation 
cycle. This allows very rapid changes in protein synthesis. Peptide hormones (insulin 
and insulin-growth factor 1, IGF-1), glucocorticoids and amino acids have all been 
implicated in such regulation.  
Studies performed in experimental cell models have revealed the importance of Akt 
factors (also called protein kinase B) in the regulation of protein synthesis in skeletal 
muscle. Akt factors are serine/threonine-specific protein kinases playing a critical role 
in muscle hyperthrophy (Bodine SC et al., 2001). Activation of signaling cascades 
involving IGF-1 and phosphatidylinositol 3-kinase (PI3K) induces Akt phosphorylation 
and activation (Bodine SC et al., 2001). Akt, in turn, activates the eukaryotic translation 
initiation factor 2B (eIF2B) by stimulation of glycogen synthase kinase-3β (GSK-3β) 
(Rhoads RE 1999). In parallel, Akt can activate initiation of protein translation 
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stimulating p70S6 kinase (p70S6K) by mammalian target of rapamycin (mTOR) 
protein-kinase (Terada N et al., 1994). Interestingly, a period of resistance training 
exercise induces muscle hypertrophy associated with increases in phosphorylated Akt, 
GSK-3b and mTOR (Leger B et al., 2009). 
Insulin is a potent anabolic stimulus for MPS (Fujita, S et al. 2006). Insulin deficiency 
leads to a protein catabolic state with loss of muscle mass, reversible only by insulin 
therapy (Abu-Lebdeh HS & Nair KS 1996). Nonetheless, the mechanisms by which 
insulin enhances muscle protein anabolism are still debated (Biolo G et al 1995; Nygren 
J & Nair KS 2003; Wolf RF et al 1992; Denne SC et al 1991; Heslin MJ et al 1992; 
Moller-Loswick AC et al 199). Some studies reported that this effect was due to an 
increase in protein synthesis with no major changes, or some reduction, in proteolysis 
(Biolo G et al 1995; Nygren J & Nair KS 2003; Wolf RF et al 1992); other studies 
found a significant reduction in protein degradation with no significant changes in 
protein synthesis (Denne SC et al 1991; Heslin MJ et al 1992; Moller-Loswick AC et al 
1994). 
A stimulatory effect of insulin on protein synthesis has been demonstrated in various 
tissues, including skeletal muscle (Garlick PJ & Grant I 1988; O’Connor PM et al 
2003). Furthermore, recent human experiments have shown that insulin can acutely 
stimulate muscle protein synthesis by increasing the initiation of mRNA translation 
(Guillet C et al 2004; Kimball SR et al 1997). Insulin can also reduce protein 
breakdown by stabilizing lysosomes and reducing the activity of the ubiquitin-
proteasome pathway (Lee SW et al 2004). 
Protein intake and amino acid availability are key regulators of muscle protein 
synthesis. Acute AA administration up regulates muscle protein synthesis and such 
effect is enhanced if the intake is associated with resistance or aerobic exercise (Biolo G 
et al., 1997). In contrast to exercise, the anabolic efficiency of amino acid 
administration is decreased during inactivity. The stimulatory effect of an amino acid 
load on whole body protein synthesis in healthy volunteers at the end of a period of 
experimental bed rest was reduced (-20%), when compared to individuals with normal 
physical activity (Biolo G et al., 2004). Furthermore during bed rest, the rate of protein 
turnover, in the fasting state, was decreased both at skeletal muscle and whole body 
levels (Biolo G et al., 2004). Other studies showed that dietary protein restriction (i.e., 
0.6g protein/kg/d) led to 23% suppression of whole body protein turnover, in the fasting 
state, when compared to adequate levels (i.e., 1.0g protein/kg/d) of protein intake 
(Stuart CA et al., 1990). Other Authors, maintained leg mass and ameliorated the 
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muscle strength losses following 4 weeks bed rest by a daily supplementation of about 
50g of essential amino acids (Paddon-Jones D et al., 2004). 
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1.1.2. Protein breakdown 
Several proteolytic systems can contribute to the degradation of muscle proteins, among 
these, the most relevant are the following: 
• The lysosomal-autophagic system which is present in all cells and involves acid 
proteinases (i.e. cathepsins), active within a vacuolar structure capable of engulfing and 
degrading complete organelles, ribosomes, as well as intracellular proteins and proteins 
entering the cells via endocytosis. 
• The ubiquitin-proteasome ATP-dependent system, widely distributed among 
tissues, is characterized by relative broad protein specificity for the hydrolysis of 
proteins and peptides. It involves two components: a) the recognition system 
responsible for targeting the protein substrates toward proteolysis and b) the 
multifunctional proteasome, causing the proteolysis. In the proteasome system, 
degradation is carried out by the 26S subunit (Grune T et al., 2003; Grune T & Davies 
KJ 2003), which is composed by the 20S and by the regulatory 19S complex, the latter 
playing an important role in adenosine triphosphate (ATP)-dependent degradation 
(DeMartino GN & Ordway GA 1998). Protein substrates are marked for degradation in 
the 26S proteasome pathway by covalent addition of ubiquitin. This requires the 
ubiquitin- activating enzyme (E1), specific ubiquitin-conjugating enzymes (E2), and 
ubiquitin protein ligase enzymes (E3). The ubiquitin E3 ligases, atrogin1 and muscle 
ring finger-1 (MuRF-1), are involved in skeletal muscle atrophy (Bodine SC et al. 2001; 
Gomes MD et al., 2001). MuRF-1 was shown to be directly and indirectly upregulated 
by Forkhead family of transcription factors (FoXO) (Stitt TN et al., 2004) and by the 
NF-kB transcription factor (Sandri M et al., 2004). Ubiquitinated proteins are 
recognized and bound by the 19S regulators of the 26S proteasome, that removes the 
polyubiquitin chain and unfolds the substrate protein for final degradation into the 20S 
core proteasome (Grune T et al., 2003). 
• The calcium-activated calpain and calpastin pathway is responsible for the 
initiation of proteolysis. In vitro and animal studies, showed that Ca2+-activated 
proteases (Calpain) and the proteasome system play important roles in muscle protein 
breakdown during muscle atrophy (Furuno K & Goldberg AL 1986; Ikemoto M et al., 
2001; Purintrapiban J et al., 2003). Moreover, caspase-3 may also contribute to selected 
forms of muscle atrophy (Du J et al., 2004). Actomyosin complexes represent 50–70% 
of muscle proteins (Tidball JG & Spencer MJ 2002). The proteasome system can 
degrade only monomeric contractile proteins (i.e. actin and myosin) (Goll DE et al., 
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2003), which, therefore, must be released from actomyosin complexes to be degraded 
by the proteasome (Goll DE et al., 2003). Both calpain and caspase-3 can play a key 
role in producing actomyosin disassociation (Du J et al., 2004; Goll DE et al., 2003; 
Tidball JG & Spencer MJ 2002). Calpain activity is increased by an elevation in 
cytosolic calcium concentrations (Goll DE et al., 2003). Caspases are cascade-activated 
proteases triggered by several signaling pathways (Primeau AJ et al., 2002): whose 
activation can result in protein breakdown and apoptosis. 
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1.2. Protein requirement in adults 
Daily protein requirement is influenced by multiple factors the most relevant being the 
obligatory nitrogen losses which were measured in fasting subjects, with stable body 
weight, with modest levels of physical activity (Shils ME et al. 2006; Caballero B et al. 
2012; Guarnieri G et al 1998). On the average this value is equal to 4,4 g/day, about 27 
g of proteins considering a conversion factor of 6,25 (1g N = 6.25g protein), being 
nitrogen about 16 % of proteins by weight. This minimum protein requirement (0.34 
g/kg/day) were raised to 0,8 g/day to adjust for the individual variability and for factors 
such as the differences in biological values and of the net protein utilization of proteins 
from different food sources. The biological value (BV) of proteins is an index of the 
body capacity to utilize them in anabolic processes. It is equal to the ratio between the 
retained nitrogen, RN and the absorbed nitrogen AN.  
VB = RN/AN. 
Where 
AN = [Nitrogen intake – (nitrogen excreted in the feces after the intake of proteins – 
nitrogen excreted on an aproteic diet)] 
and  
RN= AN – (urinary nitrogen after the intake of proteins – urinary nitrogen excreted on 
an aproteic diet). 
Proteins from animal sources have higher biological values than those from vegetable 
food. The net protein utilization (NPU) defines, besides biological value also protein 
digestive efficiency and it is equal to the ratio between the retained and the dietary 
nitrogen (nitrogen intake). 
NUP=R/I. 
The correction factor for the definition of protein requirements considers an NPU of a 
mixed diet, with proteins from different sources. The NPU of various proteins present in 
the same food may also differ, as in the case of milk proteins, with whey and casein 
being considered respectively a fast protein and a slow protein, in reaching the sites of 
body protein synthesis (Shils ME et al. 2006; Caballero B et al. 2012; Guarnieri G et al 
1998).  
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1.2.1. Recommended dietary allowances for protein in adults 
The latest recommended dietary allowances (RDAs) in the USA, Europe and Italy have 
maintained the indication for a daily protein intake of 0,8 g/kg body weight, in all 
healthy adults, males and females, excluding pregnancy or lactation, independently 
from age (World Health Organization (WHO) 2007; European Food Safety Authority 
(EFSA) 2012). The adaptation of the body to a low or zero nitrogen intake is shown in 
figure 3: urinary N excretion drops dramatically in response to the protein-deficient diet 
over the first 3 days and thereafter stabilize a new lower level of N excretion by day 8.  
 
 
Figure 3. Physiological adaptation to a low or absent nitrogen intake 
From Caballero B et al. 2012 
Table 1 also illustrates how urea production is related to N intake and how the body 
adapts oxidation of amino acids to their supply.  
Table 1. Physiological nitrogen-related urea production in the body 
 
From Caballero B et al. 2012 
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placement of healthy subjects on a diet containing a mini-
mal amount of protein. As shown in Figure 1.7, urinary N 
excretion drops dramatically in response to the protein-
deficient diet over the first 3 days and stabilizes at a new 
lower level of N excretion by day 8 (40).
The N end products excreted in the urine are end prod-
ucts not only of amino acid oxidation (urea and NH3) but 
also of other species such as uric acid from nucleotide deg-
radation and creatinine (Table 1.8). Fortunately, most of 
the nonurea, non-NH3 N is relatively constant over a vari-
ety of situations and is a relatively small proportion of the 
total N in the urine. Most of the N is excreted as urea, but 
NH3 N excretion will increase significantly when subjects 
become acidotic, as is apparent in Table 1.8, when subjects 
have fasted for 2 days (41). Table 1.8 also illustrates how 
urea production is related to N intake and how the body 
adapts its oxidation of amino acids to follow ami o acid 
supply. In other words, with an ample supply, excess amino 
acids are oxidized and urea production is high, but with an 
insufficient supply of dietary amino acids, amino acids are 
conserved and urea production is greatly decreased.
N appears in the feces because the gut does not 
completely absorb all dietary protein and reabsorb all N 
secreted into the gastrointestinal tract (see Fig. 1.6). In 
addition, N is lost from skin via sweat as well as through 
shedding of dead skin cells. Moreover, additional losses 
occur through hair, menstrual fluid, nasal secretions, and 
so forth. As N excretion in the urine decreases in the case 
of subjects on a minimal protein diet (Fig. 1.7), it becomes 
increasingly important to account for N losses through 
nonurine, nonfecal routes (42). The loss of N by these var-
ious routes is shown in Table 1.9. Most of the losses that 
are not readily measurable are minimal (,10% of total N 
loss under conditions of a protein-free diet in which adap-
tation has greatly reduced urinary N excretion) and can be 
discounted by use of a simple offset factor for nonurine, 
nonfecal N losses. Where the assessment of losses comes 
into play is in the finer definition of where zero balance 
occurs as a function of dietary protein intake for the pur-
pose of determining amino acid and protein requirements. 
As discussed later, small changes in N balance corrections 
make significant changes in the assessment of protein 
requirements using N balance.
Although the N balance technique is useful and simple, 
i  provi es no information about the inner workings of the 
system. An interesting analogy for the N balance technique 
is illustrated in Figure 1.8, in which the simple model of 
N balance is represented by a gumball machine. Balance 
is taken between “coins in” and “gumballs out.” We should 
not come to the conclusion that the machine turns coins 
into gum, however, even though that conclusion is easy 
to reach with the N balance method. What the N balance 
technique fails to provide is information about what occurs 
within the system (i.e., inside the gumball machine). Inside 
the system is where the changes in whole body protein syn-
thesis and breakdown actually occur (shown as the smaller 
arrows into and out of the Body N Pool in Figure 1.8). A 
further illustration of this point is made at the bottom of 
Figure 1.8, in which a  positive increase in N balance has 
been observed going from zero (case 0) to positive balance 
(cases A to D). A positive N balance could be obtained 
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Fig. 1.7. Time required for urinary nitrogen (N) excretion to stabilize 
after changing from an adequate to a deficient protein intake in young 
men. Horizontal solid and broken lines are mean 61 standard devia-
tion for N excretion at the end of the measurement period. (Data from 
Scrimshaw NS, Hussein MA, Murray E et al. Prot in requirements of 
man: variations in obligatory urinary and fecal nitrogen losses in young 
men. J Nutr 1972;102:1595–604, with permission.)
TABLE 1.8  COMPOSITION OF THE MAJOR NITROGEN-
CONTAINING SPECIES IN URINE
N SPECIES
HIGH-PROTEIN 
DIET (g N/d)
LOW-PROTEIN 
DIET
FASTING 
(DAY 2)
Urea 14.7 (87%) 2.2 (61%) 6.6 (75%)
Ammonia  0.5 (3%) 0.4 (11%) 1.0 (12%)
Uric acid  0.2 (1%) 0.1 (3%) 0.2 (2%)
Creatinine  0.6 (4%) 0.6 (17%) 0.4 (5%)
Undetermined  0.8 (5%) 0.3 (8%) 0.5 (6%)
Total 16.8 (100%) 3.6 (100%) 8.7 (100%)
N, nitrogen.
Data from Folin (1905) and Cathcart (1907), cited in Allison JB, Bird 
JWC. Elimination of nitrogen from the body. In: Munro HN, Allison 
JB, eds. Mammalian Protein Metabolism. New York: Academic Press, 
1964:483–512, with permission.
TABLE 1.9  OBLIGATORY NITROGEN LOSSES BY MEN ON 
A PROTEIN-FREE DIET
DAILY NITROGEN LOSS
AS NITROGEN 
(mg N/kg/day)
AS PROTEIN EQUIVALENT 
(g PROTEIN/kg/day)
Urine 38 0.23
Feces 12 0.08
Cutaneous  3 0.02
Other  2 0.01
Total 54 0.34
Upper limit 
(12 standard 
deviations)
70 0.44
Data from Munro HN. Amino acid requirements and metabolism and 
their relevance to parenteral nutrition. In: Wilkinson AW, ed. Parenteral 
Nutrition. London: Churchill Livingstone, 1972:34–67, with permission.
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In other words, with a high intake, excess amino acids are oxidized and urea production 
is high, but with an insufficient supply of dietary amino acids, amino acids are 
conserved and urea production is greatly decreased (Shils ME et al. 2006; Caballero B 
et al. 2012; Guarnieri G et al 1998). A reduced protein intake increases the efficiency of 
nitrogen retention and may therefore not be indicative of an improved tissue protein 
anabolism. The validity of nitrogen balance in the definition of protein requirement 
have been therefore questioned. Furthermore, any change in protein intake requires time 
to reflect metabolic changes. Methods of assessment may also not be precise, collection 
of urine may not be complete over the 24 hours and it is difficult to estimate 
unmeasurable nitrogen losses through non-urinary, non-fecal routes (Shils ME et al. 
2006; Caballero B et al. 2012; Guarnieri G et al 1998), shown in Table 2. 
Table 2. Physiological nitrogen-related urea production in the body 
 
From Caballero B et al. 2012 
Recent studies have shown that nitrogen requirements are increased in the elderly or 
during acute and chronic illnesses, as being confirmed through higher-level 
methodologies.  
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1.2.2. Tracer methods to define amino acid kinetics.  
Tracers are compounds, chemically identical to the endogenous metabolites, but with 
one or more atoms substituted by its nonradioactive stable isotope, thus allowing a 
“labeling” useful to follow the metabolic fate of the compound (the tracee) being 
evaluated (Wolfe RR, 2002). This substitution makes the tracers distinguishable and 
measurable from the normal metabolites (Wolfe RR, 2002). Because isotopes differ 
only in the number of the constituent neutrons they can be identify by mass 
spectrometry (GCMS). The molar ratio of the amount of tracer isotope divided by the 
amount of unlabeled material is called “tracer-to-tracee ratio” (TTR) or enrichment 
(Wolfe RR, 1992). Isotopic methods are frequently used to study protein and amino 
acid metabolism. Amino acids are constantly exchanged between the intracellular and 
the extracellular pools, through the action of specific transporter. Amino acids from 
intracellular protein catabolism enter the intracellular pool and can then follow three 
paths: protein synthesis, catabolism inside the cell or passage into the plasma. Amino 
acids have a Rate of Appearance (Ra) in the intracellular pool, since they can either 
derive from plasma and/or protein catabolism, and a Rate of Disappearance (Rd) due to 
their incorporation in a protein or degradation. Generally it is assumed that during the 
study period every amino acid entering in the protein pool will be, either metabolized or 
incorporated in to a protein, with an irreversible loss (Wolfe RR, 1992).  
Furthermore it is also assumed that when the enrichment of the tracer in the pool is at 
the plateau (i.e. isotopic equilibrium) the Ra of the compound (endogenous production 
+ exogenous infusion) is equal to its Rd: 
 
Ra=Rd 
 
If the tracer is administered through a constant infusion, the kinetics is described by the 
single-pool model. When the isotopic equilibrium is reached, the Ra of the tracee can be 
calculated as the ratio between the amount of the infused tracer and the isotopic 
enrichment at its plateau. A priming dose (bolus), at the start of the infusion, allows to 
reduce the time required to reach the isotopic equilibrium (Wolfe RR, 1992).  
Isotopic methods are applied through the following techniques:  
1. Precursor incorporation 
2. Tracer dilution 
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The precursor incorporation technique requires a constant infusion of a tracer, usually 
after priming bolus, to measure, when reaching the isotopic equilibrium, anabolism 
from its incorporation rate into a protein (Wolfe RR, 1992). The tracer dilution 
technique is applied to measure the Ra and the Rd of a metabolite in a given pool. Since 
the tissues do not separate the tracer form the trace, the Rd does not modify the tracer 
substrate ratio, therefore any isotopic enrichment change is the consequences of the 
dilution effects of the unlabelled substrate (Wolfe RR, 1992). 
The most frequently used stable-labelled isotopes for the investigation of protein 
metabolism are: 15N-Glycine, 13C-Leucine, 15N-Leucine, L-[ring-2H5]-Phenylalanine. 
L-[ring-2H5]-Phenylalanine (D5-Phe) is very useful in the study of protein metabolism. 
This essential amino acid is not peripherally catabolized, therefore, in the fasting state, 
its irreversible disappearance from the pool can be due only to protein synthesis or 
irreversible hydroxylation to tyrosine. On the other side, the appearance of the 
unlabelled phenylalanine can only derive from protein catabolism. Thus the 
administered D5-Phe produces an amount of 2H4-Tyrosine (D4-Tyr) indicative of net 
protein catabolism. If together with the labelled phenylalanine a labelled tyrosine is 
administered (e.g. 2H2-Tyr), it is possible to determinate the rate of phenylalanine 
hydroxylation (Figure 4) (Matthews DE 2007). 
 
 
Figure 4. Phenylalanine and tyrosine kinetics in human 
 
These methods, when requiring intravenous infusions of an extemporarily-made 
solutions, administered through two catheters, imply the preparation of apyretic and 
aseptic infusate, a process which needs a dedicated area and controlled conditions, not 
always readily available. Furthermore, the infusion protocols are usually time-
consuming needing up to 6 to 7 hours. All these factors can reduce the compliance of 
the examined subjects and increase costs and efforts. 
There are also other methods limitation that should be taken in to account. The model 
shown in the figure 4 assumes that all proteins have a slow turn-over and therefore will 
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not modify the amino acids entering and living the pool, from catabolism and synthesis 
respectively. However some proteins have a very short half-life (e.g. enzymes) (Wolfe 
RR, 1992). 
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1.3. Factors influencing protein requirements in different conditions. 
As argued above, the guidelines for dietary protein need traditionally consider a similar 
requirement for all adults, regardless of age or sex (0.8g/kg/day of protein) (WHO 
2007; EFSA 2012). However, new evidences (Bauer J et al. 2014) have shown that a 
higher dietary protein intake is effective to support good health, promote recovery from 
illness and preserve functionality in elderly subjects (aged over 65 years) (Walrand S et 
al 2011; Gaffney-Stomberg E et al 2009; Kurpad AV& Vaz M 2000; Morse MH et al 
2001; Chernoff R. 2004; Morley JE et al 2010). An increased consumption of proteins 
with diet can overcome the decline of the anabolic response to dietary protein, and 
offset inflammatory and catabolic states associated with chronic and acute disease. 
These conditions occur often in elderly individuals (Walrand S et al 2011), whose 
generally consume less protein than young adults (Bauer J et al. 2014). An insufficient 
protein provision can also lead to loss of muscle mass and strength and, as a 
consequence, older people are at higher risk for conditions such as sarcopenia and 
osteoporosis than are younger individuals (CederholmTE, et al 2011; Cruz-Jentoft AJ et 
al 2010; De Souza et al 2010). 
1.3.1. Sarcopenia 
Sarcopenia from the Greek σάρξ, "flesh" and πενία, "paucity" defines a condition 
characterized by reduced muscle mass, associated with loss of strength or performance. 
The European Working Group on Sarcopenia in Older People (EWGSOP) has recently 
defined sarcopenia as a “syndrome characterized by progressive and generalized loss of 
skeletal muscle mass and strength, with a risk of adverse outcomes such as physical 
disability, poor quality of life and death.” (Cruz-Jentoft AJ et al. 2010). Moreover, The 
EWGSOP group classified sarcopenia as primary (or age related, associated with the 
physiological changes induced by the aging process), and secondary (caused by other 
factors such as inactivity, illnesses and nutritional problems, including malabsorption or 
other gastrointestinal disorders or medications, causing appetite loss). Recently, 
however, some authors disagreed with this etiological classification since in most cases, 
muscle loss is induced by multiple factors, difficult to identify separately (Biolo G et al. 
2014). This is particularly true in the ageing population, characterized by a higher 
prevalence of chronic and acute diseases. 
  
 21 
Causes and consequences  
Sarcopenia and the associated body composition changes are caused by multiple factors 
including the so called “anorexia of aging”, i.e. reduced food intake, seen with 
advancing age, hormonal changes, such as reduced synthesis of growth and sex 
hormones, resistance to leptin, insulin and thyroid hormones, and neurodegenerative 
processes. Other contributing factors include hereditability, intake of proteins (type and 
quantity) and energy, vitamin D status, physical inactivity, increased adiposity and 
chronic and acute diseases (Bauer J et al. 2013) (Figure 5).  
Aging is characterized by changes in protein metabolism: protein turnover is reduced 
with lower protein synthesis and increased catabolism, leading to a net decline in 
protein synthesis. These changes are sustained by a higher splanchnic extraction of 
amino acids, that impairs their availability, a blunted response to the anabolic stimulus 
(anabolic resistance) of protein feeding and a reduced anticatabolic effect of insulin. 
 
 
Figure 5. Loss of skeletal muscle mass and function characterize sarcopenia of 
both aging and diseases.  
From Biolo et al 2014 
 
4.2. Energy expenditure and muscleefat interaction
Skeletal muscle mass is a major determinant of daily energy
expenditure at rest and during physical activity. In physiological
conditions, the metabolic rate of skeletal muscle accounts for about
20% of whole body resting energy expenditure.51 When measured
by indirect calorimetry, resting metabolic rate is strictly propor-
tional to lean body mass. In 6-week experimental bed rest studies
in healthy young volunteers, muscle disuse atrophy was associated
with 38% decrease in energy expenditure for physical activity52 and
with 6% decrease in resting energy expenditure, i.e., about 30e
40 kcal/day for each kg of lean body mass lost throughout the
experimental period.53 Energy expenditure and requirement are
greatly decreased in patients with severe inactivity-related sarco-
penia.54 In patients with muscle wasting, energy requirement,
calculated by equations based on body weight, is constantly over-
estimated.55 Thus, in all conditions of muscle disuse atrophy energy
requirement is decreased due to reductions in both resting and
activity-related energy expenditure. The rate of fat deposition tends
to increase, especially at the abdominal level,56 leading to activa-
tion of systemic inflammation57,58 and insulin resistance.59e61
These alterations enhance the catabolic effect of inactivity.58 This
vicious cycle (Fig. 4), that leads to progressive muscle loss and fat
gain, is frequently observed in some patients with chronic diseases
and cancer as well as in sedentary lifestyle and in aging. In fact, total
energy expenditure decreases substantially in aging resulting from
parallel changes in resting metabolic rate and activity.62 Resting
metabolic rate may be increased in selected chronic diseases.
Amyotrophic lateral sclerosis is characterized by severe disuse at-
rophy, while resting energy expenditure is increased leading to
weight loss and cachexia.63,64 Hypermetabolism may also occur in
sub-groups of stable patients with LC or COPD.65,66 Hypermetabolic
patients suffering from chronic diseases have a poor prognosis. The
origins of such hypermetabolism need to be elucidated.
4.3. Impaired contractility and muscleebone interaction
Although muscle mass determines contraction strength, clear
evidence indicate that the relationship between muscle mass and
contractile function is highly variable. Strength does not decrease
proportionally to muscle mass.67 Decreased contractility leads to
loss of strength (i.e., dynapenia), fatigue, disability and falls,
impaired pulmonary ventilation as well as to osteoporosis and
fractures due to reduced mechanical bone stimulation.4 Dynapenia
is a key determinant of quality of life and an indicator of loss of
independence in chronically ill patients and in the elderly. Muscle
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bone fractures, dyslipidemia, metabolic syndrome, type 2 diabetes, 
increased cardiovascular risk, impaired immunity, infections, etc.
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Fig. 3. Skeletal muscle loss and dysfunction characterize sarcopenia of aging and chronic diseases. Sarcopenia increases morbidity and mortality in aging as well as in cancer,
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G. Biolo et al. / Clinical Nutrition 33 (2014) 737e748 741
 22 
Besides amino acid availability, physical activity, with muscle loading, also exerts 
anabolic effects, both in muscles and in bones. Inactivity is common in the elderly, 
caused by loss of strength, overweight, balance and locomotion disturbances, fear of 
falls, low motivation and presence of diseases (Biolo G et al. 2014). This sedentary 
lifestyle may contribute to the decline of mass and function in muscle and bone tissues. 
Bed rest, that is a condition of prolonged and total muscle unloading, in experimental 
condition, causes a loss of 3-5% of lean body mass in young healthy subjects (Biolo G 
et al. 2014). 
The loss of muscle mass in sarcopenic subjects causes a reduction in the basal metabolic 
rate and in physical activity energy requirements (Biolo G et al. 2014). These changes, 
if not compensated by lower energy intake, or by a heightened energy expenditure, 
through increased physical activity, as often is the case with ageing, may lead to an 
increased fat deposition (Biolo G et al. 2014). Furthermore physical inactivity itself 
leads within a two weeks, short term period to an accumulation of visceral fat, and 
insulin resistance, as shown in young subjects who reduced experimentally their level of 
physical activity to about 15% of the basal level (Biolo G et al. 2014). Sarcopenia 
therefore is generally associated with an increase in the percentage of body fat which 
can lead to a condition called sarcopenic obesity (Biolo G et al. 2014). This rise in fat 
mass is observed in both sexes and at any given BMI, being present even in normal or 
underweight individuals. Two different pathways can lead to sarcopenic obesity, the 
first is that associated to conditions of positive energy balance, from overfeeding, or 
long-term inactivity, in otherwise healthy individuals (Biolo G et al. 2014), the second 
is observed in selected inflammatory states such as COPD, rheumatoid arthritis, chronic 
kidney disease or chronic hearth failure (Prado CM et al. 2012). In these conditions the 
increased level of cytokines and the hormonal changes are not associated with appetite 
loss, thus fat mass is preserved or even increased (Biolo G et al. 2014). The so called 
“obesity paradox” may be explained on the basis of a larger skeletal muscle mass in 
overweight subjects induced by their higher body mass (Kalantar-Zadeh K et al. 2005). 
Fat tissue is mostly expanded at the visceral or abdominal level, with an increase in 
waist circumference, observed more frequently in females. Furthermore there is an age 
related deposition of ectopic fat at the intra-muscular, intra-hepatic and intra-pancreatic 
levels. Enlarged visceral adipocytes and activated macrophages, attracted in the adipose 
tissue by adipocyte secreted chemokines, release hormones and cytokines such as 
adiponectin, leptin, tumor necrosis factor and interleukin 6 (IL-6), giving rise to an 
inflammatory response and to insulin resistance. A higher release of free fatty acids 
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further contributes to the insulin resistance. TNF-α has direct inhibitory effects on 
insulin signaling and also increases the release of free fatty acids (FFA) from adipose 
tissue. These changes increase the risk of developing type II diabetes, metabolic 
syndrome and cardiovascular complications (Biolo G et al. 2014).  
Recently it has been shown that, besides fat tissue, also skeletal muscle can be 
considered an endocrine organ, producing peptides both anabolic (insulin-like growth 
factor, IL-15) and catabolic (myostatin) and cytokines, called myokines including IL-6, 
IL-8 and IL-15 (produced during muscle contraction) (Biolo G et al. 2014). Physical 
activity increases the muscle synthesis of IL-6 with useful metabolic consequences such 
an increased local glucose uptake and fat oxidation, a higher gluconeogenesis in liver 
and lipolysis in adipose tissue. IL-15 plays anabolic activity in skeletal muscle and has a 
role in lipid metabolism. 
Sarcopenia, by reducing strength and function, leads to poorer balance and higher risk 
of falls and fractures, decreased autonomy and lower quality of life, metabolic 
complications and higher morbidity and mortality. Therefore adequate countermeasures 
need to be taken (Biolo G et al. 2014).  
Currently proposed criteria for sarcopenia assessment in a clinical setting include: 
evaluation of muscle mass, determination of strength and assessment of physical 
performance (Miller MD et al 2002; Cruz-Jentoft AJ et al. 2010; Malmstrom TK & 
Morley JE. 2013). Muscle mass can be measured by many methods including 
anthropometry (Miller MD et al 2002), bioimpedance analysis (BIA) (Cruz-Jentoft AJ 
et al. 2010; Vermeeren MA et al. 2006; Norman K et al. 2012; Mijnarends DM et al 
2013), dual energy X-ray absorptiometry (DXA) (Fearon K et al. 2011; Coin A et al. 
2012), computed tomography (CT) scan (Mourtzakis M et al. 2008; Fearon K et al. 
2011), and magnetic resonance imaging (MRI). BIA cannot reliably assess skeletal 
muscle mass in patients with body fluid abnormalities, as liver cirrhosis (LC), chronic 
kidney disease (CKD), chronic heart failure (CHF) or some cancer (Norman K et al 
2012). Ultrasonography is another reliable imaging method that can be applied to the 
analysis of the musculoskeletal system, based on computerized analysis of ultrasonic 
acoustic echoes. Ultrasound imaging can allow proper estimation of muscle thickness 
changes as direct evidence of muscle alterations. Reliability of ultrasound imaging was 
validated versus MRI as a gold standard (Arbeille P et al., 2009) and moreover, this 
technique allows a proper determination of muscle fiber orientation, with respect to 
aponeurosis, i.e. pennation angle (Narici M & Cerretelli P 1998). For measurement of 
muscle strength the hand-held dynamometer is a reliable tool o assess strength in upper 
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extremities (Mijnarends DM et al 2013). This method is widely used and has been 
validated in many physiological and pathological conditions. Several tests of physical 
performance are available such as the gait speed, the Timed Up and Go (TUG) and the 
Short Physical Performance Battery (SPPB) which includes standing balance, gait 
speed, and chair rises (sit-to-stand) (Mijnarends DM et al 2013). The EWGSOP criteria 
for sarcopenia diagnosis are described in figure 6.  
 
 
Figure 6. EWGSOP criteria for sarcopenia diagnosis 
The diagnosis requires: the presence of low muscle mass by BIA, plus low muscle strength, or low physical performance; 
conversely, the presence of low muscle mass, normal muscle strength, and physical performance is defined as pre-sarcopenia. From 
Biolo G et al. 2014 
 
  
 25 
1.3.1.1. Anabolic resistance 
The reduced response to an anabolic stimulus, such as dietary protein intake, is defined 
“anabolic resistance” (Burd NA et al., 2013). With the onset of this condition, the MPS 
response to hyperaminoacidemia is impaired, independently from the insulin 
availability (Burd NA et al., 2013).  
In physiologic condition, in the post-prandial state, protein synthesis overcome the 
protein breakdown in order to equalize the protein loss of the fasting state. The anabolic 
resistance impairs the post-prandial protein synthesis and causes muscle mass loss 
(Deutz NE et al., 2011). In a previous study (Biolo G et al., 2004), our research group 
investigated the effects of 14-d of experimental immobilization in nine healthy young 
subjects. The study consisted in a constant infusion of both the stable isotopes L[1-13C]-
leucine, to assess the anabolic response, and of an amino acid solution to simulate the 
post-prandial condition. Our results showed a significant reduction of protein synthesis 
in the fed state, due to reduced anabolic sensitivity to the amino acids stimulation. Thus 
anabolic resistance is one of the major mechanisms of muscle atrophy during inactivity 
(Biolo G et al., 2004). On the other hand, a bout of exercise before the dietary protein 
intake, determines an improved amino acid utilization, allowing a post-prandial muscle 
muss gain (Burd G et al, 2013).   
Physical exercise associated to an adequate dietary protein intake showed an anabolic 
effect on muscle protein balance (Biolo G et al., 2005). The combined effect of physical 
exercise and increased availability of amino acids on the regulation of muscle protein 
kinetics was evaluated on healthy young subjects through an intravenous infusion of a 
balanced amino acids mixture, during rest and after a resistance exercise (Biolo G et al., 
1997). The results obtained, from muscle protein kinetics with the infusion of stable 
isotopes, suggested that the MPS amino acids stimulatory effects is increased by the 
exercise session. These evidences (Figure 7) are probably due to the augmented blood 
flow promoted by physical activity. Accordingly, the amino acids derived from dietary 
proteins may have a greater anabolic effect if administered immediately after physical 
activity (Biolo G et al., 1997). 
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Figure 7. Muscle protein synthesis level (F(o,m)) assessed during an amino 
acid infusion in conditions of rest and after resistance training. 
MPS is expressed as percent variation compared to basal values (*,p<0,05) (Biolo G et al., 1997).  
In elderly there is a reduced dose-response relationship between the EAA availability 
and the myofibrillar protein synthesis (Burd NA et al, 2013).  Moreover, the anabolic 
resistance in aging involves also the insulin anabolic effect, with a reduction of the 
proteolysis inhibitory effect promoted by insulin after a meal (Rennie MJ 2009), and the 
exercise anabolic effect (Russ DW et al., 2012). This resistance to anabolic stimuli, 
such as nutrition, exercise or hormones (e.g. insulin), is the basis of the impaired aging 
muscle protein turnover (Russ DW et al., 2012). 
Cuthbertson and colleagues were the first to compare the levels of protein synthesis, 
following the oral administration of EAA, in young and elderly individuals. They 
showed that the basal levels of MPS in fasting state, were comparable in both young 
and elderly groups, but after the assumption of EAA the MPS response in elderly 
individuals was lower than that showed by the young subjects (Cuthbertson D et al., 
2005). Another study demonstrated that in elderly individuals the ability of insulin and 
amino acids, especially branched (BCAA), to stimulate the protein transduction 
processes is reduced compared to the young subjects (Guillet C et al., 2004). 
These results were sustained by other findings showing that the reduced vasodilator 
response to insulin, in aging muscles, can play a key role in the onset of the anabolic 
resistance, possibly because of a lower muscle availability of nutrients (Rasmussen BB 
et al., 2006). Breen et al. also confirms the detrimental effect of aging on anabolic 
sensitivity. They have demonstrated that after a single bout of endurance training, the 
physiological acute alterations of the MPS are compromised (Breen L. & Phillips SM 
2011). Moreover it was observed that even after 3/6 h after the physical activity, an 
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elderly subject does not reach the normal level of MPS stimulation (Drummond MJ et 
al. 2008). The detrimental effects of physical inactivity on the levels of protein 
synthesis are confirmed by a recent study showing that two weeks of sedentary lifestyle 
is associated with loss of gravitational muscle mass, involving mainly the lower limbs 
(Krogh-Madsen R et al.,2010). An active lifestyle in aging can be critical to maintain 
adequate sensitivity to an anabolic stimulus (Burd NA et al. 2013). The anabolic 
resistance in aged is represented in figure 8. 
 
Figure 8. Protein metabolism trend after an anabolic stimulus (physical activity 
and/or amino acids intake) in young and elderly subjects. 
The shaded sections mark the difference between elderly and young people in the MPS after an anabolic stimulus (from Breen & 
Phillips, 2011). 
The age-related sarcopenia has a multifactorial etiology and the mechanisms associated 
to the anabolic resistance development require further investigation, however, the 
reduction of physical activity levels (i.e. sedentary lifestyles) and/or the potential 
presence of acute or chronic diseases could have a role.  
Accordingly, some studies showed that both protein turnover and anabolic sensitivity 
could be altered by the development of an inflammatory condition, associated with 
aging (Breen L & Phillips SM, 2011). The role of inflammation on the alteration of 
protein metabolism has been extensively studied. In humans an association was found 
between MPS levels and plasma concentrations of several inflammation markers (Toth 
MJ et al., 2005). 
Many cytokines, and particularly the TNF- α could alter MPS though the inhibition of 
the phosphorylation of the proteins involved in the mTOR pathway. It was 
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demonstrated that mTOR signaling is crucial to stimulate the MPS after endurance 
training and furthermore, the phosphorylation of the proteins involved in this pathway 
seems to be enhanced by the availability of amino acids (Breen L & Phillips SM, 2011). 
Consequently, the muscle loss and the reduced sensitivity to anabolic stimuli, observed 
during inflammation could be associated with an altered protein phosphorylations of the 
mTOR signaling pathway. This mechanism could affect the elderly individuals. The 
development of a low-grade inflammation may reduce their sensitivity of this signaling 
pathway to a load of amino acids, thus determining anabolic resistance and reduced 
levels of MPS (Breen L & Phillips SM, 2011) 
Recent studies suggest an impact of the oxidative stress on the inactivity-related muscle 
mass loss, probably determining an unbalance between protein synthesis and 
degradation (Pellegrino MA et al., 2011). However further investigation are needed to 
better understand the pivotal mechanism of such influence. 
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1.3.1.2. Insulin resistance 
Insulin is a peptide hormone secreted by the β-cells of the pancreatic islets of 
Langerhans that maintains normal blood glucose levels by facilitating cellular glucose 
uptake. Besides carbohydrate metabolism, insulin regulates also lipid and protein 
metabolism and cell division and growth (Bailey CJ et al 2010). 
The term “insulin resistance” refers to a condition in which, insulin is correctly 
produced by the pancreas, but the target tissues (i.e. muscle, liver and adipose tissue) 
show a reduced sensitivity to its actions (Berg JM et al., 2012). Consequently, the tissue 
uptake of the circulating glucose is impaired in both fasting and fed state, leading to 
hyperglycemia and to detrimental effects in lipid and glucose metabolism (Silverthorn 
DU, 2010). Insulin resistance is an important T2DM risk factor and may be detectable 
even years before the appearance of hyperglycemia and T2DM. Essentially, the first 
stages are characterized by a hyperinsulinemic response to glucose that ensures a proper 
glucose metabolism (Hunter SJ & Garvey WT, 1998). In advanced stages, on the 
contrary, the even greater amount of insulin produced by the β-cells is insufficient to 
compensate the insulin resistance of the tissues, leading to hyperglycemia and T2DM 
(Reaven G, 2004). This mechanism could be one of the reasons for the development of 
T2DM during aging (Silverthorn DU, 2010).  
The cellular mechanisms responsible of the altered insulin functions may involve 
detrimental modifications for the insulin receptor, signal transduction and glucose 
transport. The major cause of the altered insulin sensitivity seems to be the missed or 
reduced translocation of the GLUT4 transporteron the cellular membrane of the skeletal 
muscle and adipose tissue, in response to the hormone; consequently, glucose 
absorption by these cells is lowered (Hunter SJ & Garvey WT, 1998). The insulin 
resistance effects vary in relation to the type of tissue and its insulin dependence for 
metabolic process regulation. The organs and tissues most affected by the altered 
insulin sensitivity are: skeletal muscle, adipose tissue, liver, endothelium, brain, 
pancreas, pituitary gland, kidney, gonads and bone (Wilcox G, 2005). The impaired 
glucose tolerance and the reduced insulin sensitivity are two common phenomena in the 
elderly population. The association between aging and insulin resistance was deeply 
investigate, since there is an increased prevalence of T2DM with ageing (Karakelides H 
et al., 2010). The progressive age-related glucose tolerance derangement depends 
mainly on the decreased tissue sensitivity to insulin and the resulting reduced ability of 
tissues to metabolize glucose (DeFronzo RA, 1981) (Figure 9). 
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Figure 9. Plasma glucose (A), insulin (B) and C peptide (C) concentrations in 
young (○) and elderly (■) subjects in fed state. 
from Basu R et al, 2003.  
This altered glucose tolerance has a multifactorial etiology and it involves mainly the 
skeletal muscle (Jackson RA, 1990). Among other factors, the reduced physical activity 
and body composition changes are critical contributors to this progressive condition 
during aging. In the elderly subjects there is a significant modification of the body 
composition with a reduction of the lean mass in favor of enhanced fat mass. Since one 
of the main actions of insulin is promoting the muscle glucose uptake, a reduced muscle 
mass could lead to insulin resistance (DeFronzo RA, 1981). An inverse relation was 
found (Srikanthan P et al. 2011) between skeletal muscle mass and insulin resistance 
and the risk of developing pre-diabetes, while an increased muscle mass was associated 
with additional protection against insulin resistance and pre-diabetes. The protective 
association was stronger in individuals with overt diabetes (Srikanthan P et al. 2011.). 
Moreover the reduced physical activity associated to aging could contribute to the 
impaired glucose metabolism (DeFronzo RA, 1981). Some authors argue that aging per 
se has a harmful effect on tissue sensitivity to insulin and consequently on glucose 
metabolism (DeFronzo RA, 1981). On the other side, recent studies suggest that the 
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age-related insulin resistance is associated to body composition changes and the 
lowered physical activity rather than aging per se (Karakelides H et al., 2010). For 
example, the increased abdominal fat mass is a key factor in the onset of insulin 
resistance (Karakelides H et al., 2010).   
Aging is also associated to a low-grade systemic inflammation and to an increased 
reactive oxygen species production (i.e. oxidative stress) (Karakelides H et al., 2010; 
Csiszar A et al., 2008). Inflammation and oxidative stress are considered two of the 
major mechanisms in the onset of the insulin resistance most likely due also to the 
higher cardiovascular risk associated to a sedentary lifestyle. The individuals affected 
by T2DM or metabolic syndrome, frequently show a low-grade systemic inflammation 
and are characterized by higher concentration of proinflammatory fatty acids in the cell 
membranes (Mazzucco S et al., 2009). Oxidative stress and low-grade systemic 
inflammation are common alterations in obese or diabetics but in aged persons they 
seems independent from body composition and may directly affect the onset of T2DM 
and cardiovascular diseases (CVD) (Karakelides H et al., 2010; Csiszar A et al., 2008). 
A good way to prevent or at least improve insulin resistance is physical activity. A 
study aiming to analyze the distinct effects of age, physical activity and fat 
accumulation on glucose tolerance and insulin sensitivity, demonstrated that regular 
physical activity can prevent the age-related insulin resistance (Seals DR et al., 1984). 
Insulin sensitivity decreases in sedentary subjects, while it is enhanced in trained 
individuals (DeFronzo RA, 1981). The detrimental effect of inactivity on insulin 
sensitivity was showed in many studies. Furthermore, experimental immobilization in 
healthy young subjects (Figure 10) caused an altered glucose tolerance and a higher 
insulin secretion. Stuart et al. showed an impaired glucose metabolism after just 7 days 
of bed rest in healthy subjects (Stuart CA et al, 1988) 
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Figure 10. Effect of 5 days of bed rest insulinaemia (upper figure) and glycaemia 
(lower figure) levels after an oral glucose load in 20 healthy subjects. 
Bed rest is associated to a significant augmented insulin (p<0,001) and glucose (p=0,03) response and thus to insulin resistance 
(from Hamburg NM et al., 2007).  
Another study (Lipman RL et al., 1972) showed that 3 days of experimental 
immobilization are sufficient to determine an impairment of about 50% of the glucose 
uptake from the tissue and an augmented level of insulinaemia and glycaemia after an 
oral glucose load. The same authors have observed that physical exercise during 
immobilization can improve insulin resistance. The bed rest state has different effects 
on trained and inactive individuals. Smorawiński and colleagues have observed the 
effects of three days of experimental immobilization on endurance and power athletes 
and sedentary subjects. After an oral glucose load, the insulin resistance-derived 
hyperinsulinemia affect both groups but the athletes (especially those performing 
resistance exercise) were more responsive. This result is probably due to a faster 
compensatory response to insulin resistance (Smorawiński J et al., 2000). Recently, a 
study has shown the association between five days of bed rest on healthy volunteers 
with dyslipidemia and altered blood pressure and vascular function (Hamburg NM et 
al., 2007). The authors propose a direct connection among the vascular dysfunction and 
the onset of insulin resistance suggesting that a lower peripheral blood flow, especially 
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in the lower limbs, could determine a reduced tissues glucose uptake (Hamburg NM et 
al., 2007). Another study comparing athletes and subjects inactive for 7-10 days, 
showed an association between physical inactivity and both an impaired glucose 
tolerance and the energy intake, while the trained subjects (controls) maintained a 
suitable glucose tolerance. This positive effect in athletes is associated to an increased 
peripheral blood flow favoring the insulin-mediated glucose uptake by the skeletal 
muscle (Arciero PJ et al., 1998; Hayashi T et al., 1997). It was also demonstrated 
(Vukovich MD et al., 1996) that the impaired insulin action evidenced after 6 days of 
physical activity in runners is associated to a reduced levels of GLUT4, the skeletal 
muscle tissues glucose transporter. These data were recently confirmed (Henriksen EJ, 
2002), however, further studies are required to verify that such mechanisms (i.e. 
impaired blood flow and GLUT4 levels) are responsible of the inactivity-related insulin 
resistance. In addition, preliminary data of our research group, showed a development 
of insulin resistance after 7 days of bed rest in healthy subjects. We have observed that 
after 35 days of experimental inactivity the insulin resistance levels are comparable to 
those measured after a week of bed rest, suggesting a rapid and full expression of this 
condition maintained in the long-term.  
Increased levels of physical activity could have a fast and healthy effect on the 
metabolic alterations determined by a sedentary life style or resting from 
hospitalization. Recently (Heer M et al., 2014) it was demonstrated that 4 days of 
regular physical activity are not sufficient for counteract the insulin resistance 
determined by 21 days of experimental inactivity. In healthy individuals 5 to 14 days of 
specific training are needed to reach again a suitable glucose metabolism. Moreover 
insulin resistance decreases after a single bout of physical exercise, in young subjects 
while in middle aged or elderly individuals several workout sections are needed to reach 
the same metabolic improvement (Henriksson J, 1995). Nonetheless further 
investigations are necessary to select the correct categories and levels of physical 
activity that could improve insulin resistance (Heer M et al., 2014). 
Insulin resistance is also associated to the so called “metabolic syndrome”, a disorder 
characterized by at least three of the following conditions: abdominal obesity, elevated 
blood pressure, hyperglycaemia, high serum triglyceride levels and low plasma HDL 
concentrations. Metabolic syndrome increases the risk of developing cardiovascular 
disease and diabetes (Kaur J. 2014). Besides the high plasma glucose levels, several 
studies suggest a direct influence of the insulin resistance on augmented VLDL hepatic 
levels, hypertension and atherosclerosis (Biolo G et al., 2005). Together these risk 
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factors are defined “insulin resistance syndrome” (Hunter SJ & Garvey WT, 1998). 
Skeletal muscle insulin resistance directly contributes to cardiovascular risk through 
induction of dyslipidemia (i.e., decreased HDL cholesterol and increased triglycerides), 
as shown in experimental bed rest studies (Mazzucco S, et al. 2010). Prolonged obesity 
leads to ectopic lipid accumulation in non-adipose tissues, particularly in skeletal 
muscles, inducing metabolic dysfunctions (reduced glucose uptake, mitochondria 
dysfunction, etc.) (Masgrau A et al. 2012). The accumulation of lipids within skeletal 
muscle, due to a blunted muscle capacity to oxidize fatty acids, is a relevant factor in 
the pathogenesis of insulin resistance. Fat infiltration is also associated with muscle 
fiber modification, decrease in muscle mass and impairment in muscle strength. Thus, 
obesity causes quantitative and qualitative alterations in skeletal muscle. This obesity-
related insulin resistance not only causes defective insulin-stimulated glucose disposal 
but has also detrimental consequences on muscle protein metabolism with a reduced 
post-prandial anabolic response. Moreover, the fat tissue release pro-inflammatory 
cytokines, including Tumor Necrosis Factor-α, interleukines and PAI-1, associated with 
the development of insulin resistance (Wilcox G, 2005). 
The best way to reduce the detrimental effect of the obesity-related insulin resistance is 
the weight loss through physical activity. 
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1.3.1.3. Inflammation  
Inflammation is a multifactorial response mediated by the activity of cytokines, which 
can have pro-inflammatory (as interleukin 1, IL-1), anti-inflammatory roles (as 
interleukin 10, IL-10) or both (as intreleukin-6, IL-6). IL-6 is also known as 
“myokyne”, as it is released by contracting muscle and is up-regulated after high 
intensity physical exercise (Petersen AM & Pedersen BK, 2006). Furthermore it has an 
immunomodulatory role, decreasing expression of pro-inflammatory cytokines and 
down-regulating the activation of factors involved in intracellular inflammatory 
response, as NF-kB and related tissue injury (Yoshidome H et al., 1999). Physical 
exercise was shown to increase also circulating IL-10 concentrations, thus suggesting 
that muscle activity can exert a beneficial anti-inflammatory action (Nunes RB et al., 
2008). Tumor necrosis factor alpha (TNF-α) is an additional important cytokine that 
plays a crucial roles in the onset and maintenance of the inflammation process, by 
stimulating acute phase reaction factors, in liver, macrophage phagocytosis and 
chemoattraction of neutrophils (Tracey KJ & Cerami A, 1990; Tracey KJ & Cerami A 
1994). Through the action on two specific cell membrane receptors, TNF-α can activate 
several biological responses as activation of NF-kB (Bouwmeester T et al., 2004) and of 
intracellular pathways leading to cell differentiation or to apoptosis (Gaur U & 
Aggarwal BB 2003). Prolonged elevation of circulating TNF-α can lead to muscle mass 
reduction: a wasting condition linked to poor prognosis of patients (Kandarian SC & 
Jackman RW 2006). Synthesis of interleukins and TNF-α can trigger the production of 
a known marker of inflammation called C-reactive protein (CRP), a factor used in 
clinical practice as marker of inflammation (Ho KM & Lipman J 2009). 
Inflammation was shown to play a crucial role in muscle mass wasting, occurring in 
healthy aging subjects (Jensen GL 2008). In particular IL-1, IL-6 and TNF-α were 
previously shown to potentially trigger muscle sarcopenia in elderly subjects (Yende S 
et al., 2006). Interestingly, physical exercise training in elderly subjects was shown to 
limit the muscle mass wasting and the synthesis of proinflammatory cytokines (Nicklas 
BJ & Brinkley TE 2009). Moreover, strength training programs in older volunteers 
ameliorated muscle strength and performance and, in parallel, increased levels of anti-
inflammatory interleukin-6 and 10 (Bautmans I et al., 2005).  
A previously published work showed in humans that experimental bed rest upregulated 
plasma CRP (+143%), the ratio between plasma IL-6 and IL-10 (4 times) and, in white 
blood cell, the ratio between IL-6 and IL-10 mRNAs (5 times) (Bosutti A et al., 2008). 
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Cytokines are direct modulators of inflammatory pathways, but other factors are also 
deeply involved in the control of inflammation. Eicosanoids, including prostaglandines 
tromboxanes and leukotrienes are key mediators and regulators of inflammation (Lewis 
RA et al., 1990). Cell availability of polyunsaturated fatty acids (PUFA) of the n-6 
series affects production of eicosanoids. Eicosanoids are synthesized from the n-6 
PUFA arachidonic acid by the enzymic action of cyclooxygenase. Arachidonic acid is, 
in turn, synthesized in separate biochemical steps from the n-6 PUFA linoleic acid, 
principally by the action of ∆6-desaturase, elongase and ∆5-desaturase (Figure 11) 
(Mazzucco S et al. 2009).  
 
Figure 11. Fatty acid biosynthesis.  
Fatty acids are metabolized by desaturases and elongases in the endoplasmic reticulum; only 24:5 n-6 and 24:6 n-3 are b-oxidized 
into the peroxisome. From Mazzucco S et al 2010 
Linoleic acid is an essential FA, contained in many vegetable oils (Bozan B & Temelli 
F 2008), which determines, together with the endogenous synthesis, the availability of 
n-6 PUFA (Wertz PW 2009). Elevated availability of n-6 PUFA in cell membranes was 
linked to inflammation (Ueda Y et al., 2008) and enhanced gene expression of 
proinflammatory cytokines and transcriptional activity of NF-kB (Weaver KL et al., 
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2009). Thus the n-6 PUFAs have a key role in the stimulation of pro-inflammatory 
processes.  
The n-3 PUFAs are synthesized from the n-3 PUFA alpha-linolenic acid in a pathway 
sharing the same enzymes involved in the n-6 series synthesis, the ∆5-desaturase. This 
enzyme leads to eicosapentaenoic acid (EPA) that is converted, by ∆6-desaturase, to 
docosahexaenoic acid (DHA) in the peroxisome. n-3 PUFA are well known to play an 
anti-inflammatory action (Figure 11). In analogy with n-6 PUFAs, alpha-linolenic acid 
and n-3 PUFAs availability are strongly conditioned by dietary intake of alpha-linolenic 
acid from vegetable oils (Wertz PW 2009), or EPA and DHA from fish (Pickova J 
2009). Fatty acids of the n-3 series are known to have an anti-inflammatory action. 
Increased intake of EPA and DHA can affect the cell membrane content of these 
PUFAs (Lee TH et al., 1985), thus reducing the fraction of the pro-inflammatory 
arachidonic acid. Increased dietary n-6 to n-3 PUFA ratio was shown to increase the 
expression of CRP and of other proinflammatory agents, as tumor necrosis factor 
(Zhang L et al., 2009). 
Phospholipids content in red blood cell membranes can be considered reliable markers 
of fatty acid availability in plasma, and of cell membrane composition in the whole 
body (Harris WS & Von Schacky C 2004). Interestingly, fatty acid membrane 
composition affects the activity of surface membrane receptors, influencing the 
activation of downstream intracellular pathways. For example, increased levels of n-3 
PUFA can enhance the expression and the signaling activity of glucose receptor 
(GLUT-4) on muscle cell membrane, thus potentially ameliorating insulin sensitivity 
(Taouis M et al., 2002). Moreover, the fraction of n-3 PUFAs in cell membranes was 
directly associated to reduced incidence of cardiovascular diseases: this effect was 
associated with the anti-inflammatory role of n-3 PUFAs and to other changes induced 
on cardiovascular system physiology by this class of fatty acids (Harris WS & Von 
Schacky C 2004). Published evidence proved that in human neutrophil membranes, 
increases in n-6 to n-3 PUFA ratios are directly associated with the ability of 
synthesizing pro-inflammatory mediators (Zhang L et al., 2009). Such evidence 
confirms that cell membrane relative content of total n-6 and n-3 fatty acids can be 
considered as a marker of whole body inflammatory condition.  
The impact of physical exercise on membrane fatty acid composition was investigated 
in several studies. Constant moderate training and acute exercise were shown to 
decrease both phosphatidylserine and polyunsaturated fatty acids in erythrocyte 
membranes: this effect was hypothesized to be caused by increased lipid peroxidation 
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due to muscle contraction (Sumikawa K et al., 1993). Another study emphasised n-6 
PUFA content changes mediated by physical exercise. The authors showed that linoleic 
acid and the sum of n-6 fatty acids were decreased in trained skeletal muscle 
phospholipids. This reveals that physical exercise can directly exert an anti-
inflammatory role at muscle level, in this way potentially ameliorating insulin 
sensitivity (Andersson A et al., 1998). Regular exercise was shown, in rats, to decrease 
∆-5 desaturase activity and arachidonic acid content; in addition, docosahesaenoic acid 
proportion in cell membrane was decreased while linoleic acid was increased (Helge 
JW et al., 1999). Observed effects on membrane composition mediated by regular 
exercise where hypothesized to be dependent on energy substrate utilization during 
training (Helge JW et al., 1999). Still, a previously published study showed in humans 
that fractions of oleic acid and docosahexaenoic acid were significantly higher in 
trained muscles when matched to untrained (Helge JW et al., 2001). Similarly, physical 
exercise significantly lowered the ratio between n-6 and n-3 PUFA in the trained 
muscle vs those untrained (Helge JW et al., 2001). This study confirmed also that 
regular physical exercise can reduce whole body and muscle inflammation.  
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1.3.1.4. Oxidative stress 
Oxidative stress is the result of an unbalance between free radicals and the activity of 
the antioxidant defense system of the body (Tchou J et al. 1991; Hardmeier R et al., 
1997) (Figure 12). 
The anti-oxidant defense includes non enzymatic and enzymatic systems. 
• Enzymatic systems. There are several enzyme systems, part of the endogenous 
defense mechanisms, which catalyze reactions able to neutralize free radicals 
and ROS, thus preventing cell damage. The major systems are: superoxide 
dismutase (SOD), catalases, glutathione peroxidase and glutathione reductase, 
the last two being part of the glutathione system. Metal ions, including iron, 
selenium, copper, zinc and manganese, act as co-factors in these reactions. 
• Non-enzymatic systems. This category includes: GSH, ascorbic acid (Vitamin 
C), tocopherols (Vitamin E), carotenoids, flavonoids, and ubiquinol.  
 
 
Figure 12. Oxidants and antioxidants agents in the human body 
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Glutathione is the most important non-enzymic antioxidant in the organism (Pastore A 
et al., 2003).  
Glutathione synthesis is achieved by the action of two ATP dependent enzymes γ-
glutamil cysteine synthetase (catalyzing the bond between glutamic acid and cysteine) 
and glutathione synthetase, leading to the final formation of reduced glutathione 
(Majerus PW et al., 1971); the first reaction being the rate-limiting step (Lu, SC 1999) 
(figure 13). 
 
Figure 13. Glutathione biosynthetic pathway 
 
 
Glutathione is further processed (figure 14), within the γ-glutamate cycle, by γ-glutamyl 
transpeptidase leading to the formation of a γ-glutamil amino acid and to the dipeptide 
cisteinglycine (Pastore A et al., 2003). γ-glutammil amino acid is then transformed to 5-
oxoprolin and glutamic acid by γ-glutamil cyclotransferase and oxoprolinase. Glutamic 
acid is re-utilized to synthesize again glutathione (Pastore A et al., 2003). 
Cysteinglycine is then catabolized to free cysteine and glycine amino acids. Cysteine is 
a limiting substrate for glutathione synthesis, but also glutamate and glycine, as direct 
glutathione precursors, can affect its synthesis rate. 
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Figure 14. The metabolic glutathione pathway or the γ-glutamyl cycle 
 
Physical exercise increases oxidative stress; Regular physical exercise enhance total and 
reduced glutathione availability (Sen CK & Packer L 2000), thus counteracting the 
effect of free radical formation. The ratio between reduced and oxidized glutathione, a 
reliable marker of glutathione system activation is increased by exercise (Ji LL 1995). 
Thus, increased availability of GSH levels, can be considered, in healthy subjects, as an 
active response of the organism to a previous release of free radicals. 
Exercise training results in an elevation in the activities of both superoxide dismutase 
(SOD) and glutathione peroxidase (GPx), along with increased cellular concentrations 
of glutathione (GSH) in skeletal muscles. In contrast, inactivity leads to redox 
unbalance both in skeletal muscle (Agostini F et al 2010) and at the systemic level 
(Biolo G et al 2008). 
Low levels of physical activity also promote oxidative stress, which, through the 
activation of specific proteases and of apoptosis (Powers SK et al., 2005; Powers SK et 
al., 2007), is involved in the processes leading to muscle atrophy (Laufs U et al., 2005). 
Our research group has investigated, for the first time, the association (Brocca L et al 
2012) in healthy subjects between immobilization and oxidative stress through human 
bed rest. The development of muscle atrophy is associated with impaired anti-oxidant 
defense systems (de Boer MD et al 2008), protein oxidation and/or lipid peroxidation 
(indices of redox imbalance), suggesting a major role of oxidative stress in disuse 
atrophy (Pellegrino MA et al 2011; Dalla Libera L et al 2009). 
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In our previous data, we observed that bed rest caused an early and persistent down-
regulation of myofibrillar protein content, impairment of antioxidant defense systems 
and redox imbalance, followed, at later stages, by muscle fiber atrophy (de Boer MD et 
al 2008). The experimental inactivity caused an early down-regulation (after 8 days) of 
the antioxidant defense system, including: superoxide dismutase (SOD - which converts 
the superoxide ion into hydrogen peroxide), peroxiredoxine (such as catalases, which 
work downstream of SOD, converting hydrogen peroxide into water), α-β-crystallin and 
some heat shock proteins (such as HspB1 and Hsp70 – which remove products induced 
by free radicals and have been shown to protect cells against oxidative damage). Only 
few components i.e. heme-oxigenase-1 (HO-1) and glucose regulated protein-75 
(Grp75), of the antioxidant system showed a transient early, 8 days, post-BR up-
regulation (Mazzucco S et al 2010). After a prolonged period of inactivity (24 days) the 
mRNA for NRF2, the major transcription factor for the expression of the antioxidant 
defense system, such as heme oxygenase-1 (HO-1), catalase, SOD, peroxiredoxins, and 
genes, involved in glutathione synthesis and function, was found to be up-regulated, 
possibly in response to the ongoing redox imbalance. In our study we observed an 
increased protein carbonylation (an index of oxidative stress) at 35-days post-BR, in 
muscle biopsy samples (Mazzucco S et al 2010; Lawler JM et al 2003), which 
correlated positively with the decreased muscle fiber, cross sectional areas (CSA) 
associated with muscle atrophy and reduced protein synthesis (Mazzucco S et al 2010). 
35 days of experimental inactivity determined also an increased muscle glutathione 
synthesis. These data correlated with the levels of protein carbonylation, suggesting the 
relevance of maintaining adequate GSH levels. Glutathione depletion can influence bed 
rest outcomes (Sastre J et al. 1989), while an increased bioavailability of glutathione 
precursors, such as cysteine or N-acetyl-cysteine, can improve glutathione system 
scavenging action (Khamaisi M et al. 2000) and reduce, in an animal model, muscle 
protein catabolism (Ling PR et al. 2007). Thus, dietary glutathione precursor 
supplementation may ameliorate immobilization outcomes. 
Inactivity leads to insulin resistance and low-grade systemic inflammation (Lawler JM 
et al. 2003). Indeed, during bed rest there is an activation of the inflammatory response 
(Lawler JM et al. 2003; Biolo G et al 2007) that is related, with reciprocal influences, to 
the increased oxidative stress and insulin resistance. We have evaluated in a 14-days 
experimental bed rest (Biolo G et al 2007) the effects of immobilization on 
inflammatory response by assessing the levels of pro-inflammatory cytokines 
(Interleukine-6, IL-6) and anti-inflammatory cytokines (Interleukine-10, IL-10) and of 
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two acute-phase proteins (C-Reactive Protein, CRP or short pentraxine and long 
pentraxin-3, PTX3). Bed rest, on eucaloric conditions, significantly increased CRP and 
IL-6 concentrations and decreased mRNA transcript levels for IL-10. 
Notably oxidative stress, trough the glutathione system, and changes in the reduced 
glutathione (GSH)/oxidized glutathione disulfide (GSSG) ratio is related to the 
inflammatory response. Indeed ROS modulate the transcription of IL-4, IL-6, IL-8 and 
tumor necrosis factor-α (TNF-α), through thiol-dependent mechanisms, while cytokines 
can mediate ROS signaling (Laviano,A et al 2007). Our preliminary data suggest that 
oxidative stress and changes in glutathione levels are associated with insulin resistance 
conditions (such as type II diabetes and obesity) (Badaloo,A et al. 2002; Ikemoto M et 
al. 2002). Decreased intracellular glutathione levels have been suggested to play a direct 
causative role in the development of impaired insulin action in adipose tissue and 
skeletal muscle (Agostini F et al 2010). Insulin resistance and deficiency are often 
associated with hyperglycemia in diabetes and critical illness and hyperglycemia seems 
to be related with generation of ROS, increased oxidative stress and decreased liver 
glutathione concentrations (Bosutti A et al. 2008). Indeed liver is the major glutathione 
storage organ and the major source of plasma glutathione; circulating erythrocytes may 
reflect the synthetic capacity of the liver in the inter-organ glutathione homeostasis 
(Haddada JJ & Harbb HL 2005). 
Cross-sectional studies identified strong relationships between insulin resistance, 
systemic inflammatory response and alterations in fatty acid (FA) composition of cell 
membrane phospholipids (Das UN 2004; Vessby B et al. 2002). The poly-unsaturated 
FAs (PUFAs) of the n-6 and n-3 series are involved in up-regulation and down-
regulation of the inflammatory response, respectively. 
We have already demonstrated that bed rest prolonged for 35 days causes increased 
insulin resistance (Lawler JM et al. 2003). These metabolic alterations were associated 
with changes in erythrocyte membrane fatty acid composition. We observed increased 
levels of pro-inflammatory n-6 PUFAs and fractional content of pro-inflammatory 
arachidonic acid, decreased levels of anti-inflammatory omega 3 PUFAs (alfa-linolenic 
and eicosapentaenoic, EPA) and of monounsaturated fatty acids. These changes were 
associated with altered activity of the enzymes Δ5 and Δ9 desaturase, affected by 
insulin action (Lawler JM et al. 2003). Low Δ5 desaturase activity decreased long-chain 
PUFA content. This may cause changes in the cell membrane physical properties, 
potentially leading to altered receptor binding capacities and further impairment of 
insulin sensitivity (Peter A et al. 2009).   
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1.3.1.5. Hypoxia 
Sarcopenia is caused by multiple factors; recently a role has been attributed to hypoxia 
(Di Giulio C et al. 2009). Conditions associated with hypoxia are aging and chronic 
respiratory diseases (i.e. COPD), obesity-related obstructive sleep apnea syndrome 
(OSAS) and cardiorespiratory disorders. During aging there is a general increased 
production of ROS with possible negative effects on proteins, nucleic acids and lipids 
and on membrane functions (Di Giulio C et al. 2009; Cataldi A & Di Giulio C. 2009). 
This higher oxidative stress can be related, among other factors, to a reduction of the 
oxygen flow from the lungs to the tissues, leading to a lower cellular pO2. The reduced 
blood flow and oxygenation of skeletal muscle, and the higher ROS production together 
with a diminished mitochondrial density (Di Giulio C et al. 2009), can contribute to the 
loss of muscle mass of aging (Gunnarsson L et al. 1996; Muller FL et al. 2007; Porter 
MM et al. 1995).  
Furthermore the normal ventilatory response to hypoxia characterized by increased 
volume and ventilatory frequency are attenuated with aging (Fukuda Y et al 1992). 
Muscle atrophy has been shown also in subjects with recurrent obstructive sleep apnea 
syndrome (OSAS), cardiopulmonary disease and in COPD patient (Di Giulio C et al. 
2009). Hypoxia is central to the pathogenesis of both OSAS and COPD, further 
sustained by inflammatory and oxidative stress pathways (Figure 15) 
 
 
Figure 15. Hypoxia, the link among COPD, OSAS, systemic inflammation, and 
muscle atrophy. 
Adapted from McNicholas WT. Am J Respir Crit Care Med. 2009 
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Patients with chronic heart failure or COPD during the course of the illness lose skeletal 
muscle mass leading to exercise limitations and lower quality of life. Epidemiological 
studies have shown that between 15-30% of COPD patients were found sarcopenic 
(Jones SE et al 2015; Biolo et al 2014; Koo HL et al 2014) with or without sarcopenic 
obesity. Sarcopenia and obesity were independent risk factors for respiratory 
complications and worsening of COPD, however, the respiratory loss was most severe 
in obese sarcopenic subjects (Koo HL et al 2014). Sarcopenic COPD patients had a 
greater airflow obstruction, were significantly older and compared to non-sarcopenic 
subjects, showed reduced quadriceps strength, functional performance and exercise 
capacity (Jones SE et al 2015).  
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2. AIM 
The aim of the present thesis was to investigate in human healthy volunteers new 
biomarkers adequate to define optimal protein intake. We based our research on recent 
studies that have determined protein needs by measuring whole-body protein 
metabolism using stable labeled isotope-amino acids. 
The present work includes two experimental protocols: 
1) The PLANHAB study on the effects of hypoxia and inactivity isolated or 
combined on muscle mass and function and protein, glucose and lipid 
metabolism, oxidative stress and inflammation. Hypoxia and inactivity can be 
considered models, in humans, of clinical conditions such as COPD, CVD and 
OSAS characterized by loss of muscle mass and function and normal or 
expanded fat tissue (sarcopenia and sarcopenic obesity). 
 
2) The INTERREG PANGeA on the effects of aging and immobilization on 
muscle mass and function, protein and glucose metabolism in elderly subjects 
compared to young controls 
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3. METHODS 
The main goal of this thesis is to find new biomarkers to define optimal protein 
requirement in physio-pathological conditions. Specifically we have investigated the 
detrimental effects of physical inactivity with or without hypoxia and in aging, on 
muscle protein synthesis. Moreover the effects of these conditions on, oxidative stress, 
inflammation, lipid metabolism and insulin sensitivity were also evaluated as related 
conditions influencing MPS. The bed rest model is known to be a reliable approach to 
study the impact of muscle unloading on human metabolism (Biolo G et al., 2005). To 
investigate hypoxia, we utilized a special structure with areas at controlled oxygen 
levels. The results reported in the present thesis were collected during two different 
European funded experimental bed rest study: 1) the FP7 PLANHAB study (Planetary 
Habitat simulation). A 7 Framework program 2007-2013 and 2) the INTERREG 
PANGeA (Physical Activity and Nutrition for Quality Ageing). Italy-Slovenia 
European Program for Cross Border Cooperation 2011-2014. 
 
3.1. Experimental procedures 
3.1.1. Whole body protein kinetics 
Whole body protein kinetics were determined in plasma by the tracer model of 
phenylalanine and tyrosine metabolism, as previously described (Antonione R et al., 
2008). 
Briefly, after an overnight fasting, two polyethylene catheters were inserted into a 
forearm vein of a subject for isotope infusion and into a wrist vein of the opposite arm, 
the latest was heated at 50°C, for arterialized venous blood collection. Before the start 
of the infusion, at time 0, a background blood sample was collected to assess the natural 
occurring isotopic enrichments of [ring-2H5]-phenylalanine, [ring-2H4]-tyrosine, 2H2-
tyrosine in plasma. After background blood collection, 7-hour primed-continuous 
infusions of [ring-2H5]-phenylalanine (3.3 µmol×kg-1×h-1) and 2H2-tyrosine (1.0 
µmol×kg-1×h-1) in parallel with a single bolus of [ring-2H4]-tyrosine (1.1 µmol×kg-1) 
(Cambridge Isotope Laboratories, Andover, MA). Blood samples were drawn 180, 300 
and 420 minutes after isotope infusion, to assess the plasma enrichments of [ring-2H4]-
tyrosine and [ring-2H5]-phenylalanine. Blood was collected in EDTA tubes, 
immediately centrifuged at 3000 g at 4°C for 10 minutes; plasma and erythrocytes were 
immediately stored at -80°C for further analysis. 
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Isotopic enrichments of phenylalanine and tyrosine, in plasma, were determined by gas 
chromatography–mass spectrometry (GC-MS) (HP 5890; Agilent Technologies, Santa 
Clara, CA) as previously described (Biolo G et al., 2008; Antonione R et al., 2008). 
Isotopic enrichments were assessed considering the following mass-to-charge ratios 
(m×z-1): phenylalanine m×z-1 234-239; tyrosine m×z-1 466-470. 
Phenylalanine appearance from protein proteolysis (Phe Ra from protein proteolysis) 
was calculated multiplying the infusion rate of [ring-2H5]-phenylalanine for the 
enrichment of [ring-2H5]-phenylalanine. The rate of phenylalanine disappearance 
through hydroxylation to tyrosine (Phe Rd to hydroxylation), an index of net protein 
catabolism, was defined as follows: 
 
Phe Rd to hydroxylation= (IRD2Tyr× ED2Tyr-1) × (ED4Tyr× ED5Phe-1) 
 
where IRD2Tyr is the infusion rate of 2H2-tyrosine; ED2Tyr is the enrichment of 2H2-
tyrosine; ED4Tyr is the enrichment of [ring-2H4]-tyrosine; and ED5Phe is the 
enrichment of [ring-2H5]-phenylalanine. Phe Rd to protein synthesis was calculated as 
the difference between Phe Ra from protein proteolysis and Phe Rd to hydroxylation 
(Figure 16).  
 
 
Figure 16. Measurement of whole body protein kinetics Humans 
In the postabsorptive state there is no entry of amino acids from dietary sources, and the flux of phenylalanine in the body is derived 
from entry of phenylalanine released from protein breakdown. That input is matched by phenylalanine removal via protein synthesis 
and via metabolic disposal by conversion to tyrosine. Therefore, the measurement of the whole body rate of appearance of 
phenylalanine in the postabsorptive state is a measure of the whole body rate of proteolysis (Matthews DE 2007).  
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3.1.2. Post-prandial anabolic resistance 
In the morning a polyethylene catheter was inserted into a forearm vein of subjects, 
fasted overnight, for blood collection. After basal blood sampling, at time 0 (t0), an oral 
load of 0.3g of 2H5-phenylalanine, dissolved in 15-20mL of water, was administred to 
the volunteers to be drank in 5 minutes. Blood samples were drawn at 30, 60, 120, 180, 
240, 300 and 360 minutes after the the loading, in EDTA tubes then immediately 
centrifuged at 3000g at 4°C for 10 minutes. Plasma was immediately stored at -80°C. 
Plasma samples were used to assess the concentration of 2H5-phenylalanine (D5-Phe) 
and 2H4-tyrosine (D4-Phe), the product of phenylalanine hydroxylation.  
 
Isotopic enrichments of plasma phenylalanine and tyrosine, derived by phenylalanine 
hydroxylation, were determined by gas chromatography–mass spectrometry (GC-MS) 
(HP 5890; Agilent Technologies, Santa Clara, CA) as t-butyldimethylsilyl derivatives 
(Biolo G et al., 2008). Plasma concentrations of leucine, phenylalanine and tyrosine 
were assessed in all samples by GC-MS, using the internal standard technique, as 
previously described (Biolo G et al., 2008). Known amounts of 13C-leucine, 13C-
phenylalanine and 2H2-tyrosine (Cambridge Isotope Laboratories) were added as 
internal standards. Isotopic enrichments were assessed considering the following mass-
to-charge ratios (m×z-1): phenylalanine m×z-1 234-239; tyrosine m×z-1 466-470. Amino 
acids in plasma were monitored using the following m×z-1: leucine m×z-1 302-303, 
phenylalanine m×z-1 336-337 and tyrosine m×z-1 466-468. 
Amino acid concentrations [aa] was determined by the internal standard technique as 
follows: 
 
[aa] = a × TTR 
 
where a is the concentration of the internal standard added to plasma samples and TTR 
(Tracer-to-Tracee Ratio) is the isotopic enrichment of the internal standard. 
 
Phe-D5 and Tyr-D4 concentrations, [aa*], was calculated as follows: 
 
[aa*]= [aa] ×TTR* 
 
where [aa] is plasma concentration of the tracee (phenylalanine or tyrosine amino acid) 
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and TTR* is the isotopic enrichment of Phe-D5 or Tyr-D4. 
The area-under-the curve (AUC), i.e., the area under the plasma amino acid 
concentration versus time curve, was estimated using the linear trapezoidal method. 
Blood was collected every 60 minutes for 6 hours. Thus the index of anabolic resistance 
was calculated as ratio between AUC Tyr-D4 and AUC Phe-D5, assessed over 6h meal 
test. 
 
AUC Tyr-D4/AUC Phe-D5 
 
A new method 
After the data analysis, we calculated the same index, using only the blood collections 
of the first two 2 hours from meal and [ring-2H5]-phenylalanine load, requiring 2 blood 
draws, over the 7 planned, and 2h, over 6 of observation. 
A simplify index of anabolic resistance was calculated as ratio between Tyr-D4 
concentration and Phe-D5 concentration measured after 2 h from meal and Phe-D5 load. 
 
[Tyr-D4]T120/[Phe-D5]T120 
 
The new, simplify index displayed similar results compared with the (bed-rest effect 
p<0.05; bed-rest×group interaction p<0.05) (R=0.75; p<0.001). 
3.1.3. Post-prandial insulin resistance  
Post-prandial state 
In the morning, a polyethylene catheter was inserted into a forearm vein of a subject, 
fasted overnight, for blood collection. After basal blood sampling, at time 0 (t0), a 
standarized test meal (500mL, 500Kcal, 55% of carbohydrate 15% of protein and 30% 
of fat; vanilla flavour, Nutricomp ®, B.Braun), was administred to the volunteers to be 
drank in 5 minutes. Blood samples were drawn at 30, 60, 120, 180, 240, 300 and 360 
minutes after the the loading, in EDTA tubes then immediately centrifuged at 3000g at 
4°C for 10 minutes. Plasma was immediately stored at -80°C. Plasma samples were used 
to assess insulinaemia and glycaemia in the fasting and fed state. 
 
Insulin and glucose levels were measured with standard procedures by a certified 
external laboratory (Synlab Italia Srl, Italy) and their values were used to calculate:  
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The Area Under the Curve (AUC) of post-load insulinemia and glycemia. 
 
The Matsuda index as parameter of insulin sensitivity in fed state. 
 
Matsuda Index =10000/√(glycT0 × insT0 × insaverage OGTT × glycaverage OGTT) 
 
Where (ins) and (glyc) indicate insulin and glucose plasma levels, respectively. 
 
Fasting state 
The HOmeostatic Model Assessment, as index of insulin resistance (HOMA-IR). 
 
HOMA index=(fasting glucose x fasting insulinemia)/405 
 
3.1.4. Amino acids 
A known amount of internal standards were added to plasma samples (200 µL) to 
determinate the concentration of unlabeled AAs. The plasma samples were 
deproteinized adding sulfosalicylic acid (200 µl, 10%). After centrifugation (4000 rpm 
per 20 min at 4°C) the supernatants were purified in a cationic resin (AG50W-X8; Bio-
Rad, Hercules, CA) using NH4OH (4N) as eluent. The NH4OH excesses were 
evaporated under N2 flux. Samples were then lyophilized and the powders obtained 
were derivatized by the addition of 50 µl acetonitrile and 50 µl MTBSTFA and by 
heating at 90°C for 45 min. After derivatization, samples were injected into a gas 
chromatography-mass spectrometer (GC-MS) (HP 5890, Agilent Technologies, Santa 
Clara , CA, USA). Gas chromatographic measurements were performed in single ion 
monitoring mode, using the following mass-to-charge ratio (m×z-1): phenylalanine 
m×z-1 336; [ring-2H5]-phenylalanine m×z-1 341; tyrosine m×z-1 466; [3,3-2H2]-
tyrosine m×z-1 468; [ring-2H4]-tyrosine m×z-1 470; homocysteine m×z-1 496; [13C]-
homocysteine m×z-1 497; [2H8]-homocysteine m×z-1 500; methionine m×z-1 320; [1-
13C, methyl-2H3]-methionine m×z-1 324; cysteine m×z-1 406; [3,3-2H2]-cysteine 
m×z-1 408. 
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3.1.5. Oxidative stress 
Glutathione synthesis rate 
In the morning, after an overnight fasting, two polyethylene catheters were inserted: one 
into a forearm vein for isotope infusion, and the other into a wrist vein of the opposite 
arm, heated at 50°C, for arterialized venous blood collection. Before the beginning of 
the infusion (time 0), a background blood sample was collected to assess the natural 
isotopic enrichments of 2H2-glycine and 2H2-glutathione in red blood cells (RBC). After 
that, a 7-hour primed-continuous infusion of 2H2-glycine (26.5 µmol×kg-1×h-1) was 
started (Cambridge Isotope Laboratories, Andover, MA). Blood samples were drawn at 
180, 300 and 420 minutes after the start of isotope infusion, to assess enrichments of 
2H2-glycine and [2H2-glycine]-glutathione in RBC. Blood, collected in EDTA tubes, 
was immediately centrifuged at 3000 g at 4°C for 10 minutes; plasma and erythrocytes 
were immediately stored at -80°C for further analysis. 
 
Isotopic enrichments of glycine and glutathione, in RBC, were determined by gas 
chromatography–mass spectrometry (GC-MS) (HP 5890; Agilent Technologies, Santa 
Clara, CA) as previously described (Biolo G et al., 2008; Antonione R et al., 2008). 
Isotopic enrichments were assessed considering the following mass-to-charge ratios 
(m×z-1): glycine m×z-1 218-220; glutathione m×z-1 363-366. Erythrocyte total 
glutathione concentrations were determined in background blood samples using the 
internal standard approach, through the addiction of known amount of [13C2-15N-
glycine]-glutathione (Cambridge Isotope Laboratories, Andover, MA). 
 
Glutathione fractional turnover rate (FTR; in % × d-1) was calculated as: 
 
[E(2H2-glutathione)×t-1]×E(2H2-glycine)-1 × 24 × 100 
 
where E(2H2-glutathione) ×t-1 is the slope of the regression line describing the rise in 
erythrocyte 2H2-glutathione enrichment as a function of time (hours); E(2H2-glycine) is 
the mean glycine enrichment in erythrocytes after steady state achievement. 
Coefficients (i.e., 100 and 24) were applied to express glutathione fractional turnover 
rate as %×d-1. The absolute turnover rate was calculated as the product of FTR and 
glutathione concentrations. 
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The ratio between the concentrations of reduced and oxidized forms of glutathione in 
erythrocytes (GSH/GSSG ratio) was assessed in the same background blood sample, by 
a commercially available kit (GT40, Oxford Biomedical Research; Oxford, MI).  
 
Glutathione synthetic capacity. 
Glutathione peroxidase activity was determined in erythrocytes according to Paglia and 
Valentine (Paglia DE & Valentine WN 1967) and expressed as µmol metabolized 
NADPH × min-1 × g protein-1 in the presence of an organic hydroperoxide 
(cumolhydroperoxide) and of reduced glutathione as enzyme cofactor. 
Catalytic and modulator subunit expression of glutamatecysteine ligase (GLC) in 
erythrocytes was measured by Western blot analysis (Thompson SA et al., 2000). 
Briefly, proteins were extracted from red blood cells by using a lysis buffer (45 mmol/L 
Tris-HCl, 0.2% Nlaurylsarcosine; Sigma-Aldrich, St Louis, MO) containing proteinase 
and phosphatase inhibitors (0.2 mM phenylmethanesulfonyl fluoride, 1 mM 
dithiothreitol, 2 µg aprotinin/mL, 2 µg pepstatin× mL- 1, 0.1 mmol NaF × mL-1, and 
0.1 mM Na3VO4; all: Sigma-Aldrich). After centrifugation (10 min, RT, 16 00 × g), 
proteins were separated by sodium dodecyl sulfate–polacrylamide gel (12%) 
electrophoresis and transferred to a nitrocellulose membrane (Protran; Perkin Elmer, 
Boston, MA). Proteins were recognized by using commercial antibodies raised against 
the catalytic (GCLc: sc-22755) and modulator (GCLm: sc-22754) (both: Santa Cruz 
Biotechnology Inc, Santa Cruz, CA) subunits of the glutamate-cysteine ligase. 
Glyceraldehyde-3-phosphate dehydrogenase was recognized by commercial antibody 
(sc- 25778; Santa Cruz Biotechnology Inc). A goat anti-rabbit horseradish peroxidase– 
conjugated immunoglobulin G (Sigma-Aldrich) was used as secondary antibody. 
Protein complexes were detected by enhanced chemiluminescence (Amersham Life 
Sciences, Arlington Heights, IL) on photographic film (Kodak Biomax Light Film; 
Sigma-Aldrich). Protein concentrations in the catalytic and modulator subunits of 
glutamate-cysteine ligase were measured by band densitometry as a ratio with 
glyceraldehyde-3-phosphate dehydrogenase protein concentration (Model 45–700 
Imaging Densitometer; Bio-Rad). 
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3.1.6. Lipid pattern 
Total cholesterol, HDL cholesterol and triglycerides were measured with standard 
methods by a certified external laboratory (Synlab Italia Srl, Italy). 
Commercially available kits were used to determine plasma concentrations of: 
− Cholesterylester transfer protein (CETP, ALPCO, Salem, NH, USA), 
− Lecithin cholesterol acyltransferase (LCAT, MyBioSource, CA, USA), 
− Lipoprotein lipase (LPL, MyBioSource, CA, USA), 
− Hepatic lipase (HL, MyBioSource, CA, USA), 
− Serum amyloid A, (SAA, Abcam, UK), 
− TNF-related apoptosis-inducing ligand (TRAIL, R&D Systems, 
Minneapolis, MN). 
 
HDL2 and HDL3 concentrations were assessed using the precipitation technique 
(chemical reagents were purchased from Gesan Production srl (Italy) and Fitzgerald 
Industries International, MA, USA). 
 
Plasma LDL cholesterol was measured by the Friedewald’s formula:  
 
total cholesterol – HDL cholesterol – (triglycerides×5-1). 
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3.1.7. Systemic inflammation  
high-sensitivity C reactive protein, was measured with standard methods by a certified 
external laboratory (Synlab Italia Srl, Italy).  
 
3.1.8. Membrane fatty acid composition  
Fatty acid membrane composition of red blood cells was analyzed modifying a 
previously published method (Burdge GC et al. 2002). Erythrocytes (200 µL) were 
washed five times with decreasing concentrations (10 mmol/L, 2.5 mmol/L; 1.25 
mmol/L; 0.625 mmol/L; 0.312 mmol/L) of phosphate buffered saline (PBS). Total lipid 
extraction was performed in 5 mL of a chloroform–methanol (2:1) solution, containing 
50 mg/L of butylhydroxytoluene as antioxidant, and 1mL of 1M NaCl solution. After 
centrifugation, the lower lipid phase was collected and dried under nitrogen flux at 40 
°C. Pellets were dissolved in toluene (500 µL), and after the addition of 1mL of a 
methanol solution containing 2% of H2SO4, were heated at 50 °C for 2 h. A neutralizing 
solution (1.0 ml, 0.25 M KHCO3 and 0.5 M K2CO3 in deionized H2O) and hexane (1 
mL) was added. After centrifugation, the hexane layer, containing fatty acid methyl 
esters (FAMEs), was collected and organic solvents were removed by N2 flux. After the 
addition of hexane (150 µL), samples were analyzed by gas-chromatography–flame 
ionization detection (GC- FID; GC 6850 Agilent Technologies, Santa Clara, CA, USA). 
Specific fatty acid standards were used to identify FAMEs by retention times in 
erythrocyte samples. A commercial mixture of purified fish oil fatty acids (Menhaden 
oil, Sigma–Aldrich, Inc, MO, US) was used to detect: oleic acid (18:1, n-9), elaidic acid 
(trans 18:1, n-9), eicosapentaenoic acid (20:5, n-3), docosapentaenoic acid (22:5, n-3) 
and docosahexaenoic acid (22:6, n-3). Retention times of myristic acid (14:00), palmitic 
acid (16:00), palmitoleic acid (16:1, n-7), stearic acid (18:00), linoleic acid (18:2, n-6), 
a- linolenic acid (18:3, n-3), eicosaenoic acid (20:1, n-9), eicosadienoic acid (20:2, n-6), 
dihomo-γ- linolenic acid (20:3, n-6) and arachidonic acid (20:4, n-6) were identified by 
commercial standards. Adrenic acid (22:4, n-6) and docosapentaenoic acid (22:5, n-6) 
were identified by commercial standards from Nu-Check Prep, Inc, MN, US. Organic 
solvents and buffering salts were purchased from Sigma–Aldrich, Inc, MO, US, if not 
differently specified. 
Area-under-the-curve of each selected peak was determined by highly standardized 
hand integration performed using commercial software (HP Chem station; Agilent 
Technologies, Santa Clara, CA, USA). 
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Erythrocyte membrane fatty acid (EMFA) composition was assessed by gas-
chromatography-flame ionization detection (GC-FID; GC 6850 Agilent Technologies, 
Santa Clara, CA, USA), as previously reported (Mazzucco et al. 2010). 
Red blood cell membrane level of each enlisted FA was expressed as percent ratio 
between area-under-the-curve of each selected EMFA peak and the sum of all measured 
EMFA peaks.  
The following indices were calculated: 
 
− Δ-5 desaturase index, as index of insulin sensitivity, was defined as ratio between 
arachidonic acid (20:4, n-6) and dihomo-γ-linolenic acid (20:3, n-6) membrane 
levels.  
− Δ-9 desaturase index, as index of insulin sensitivity, was calculated as ratio 
between oleic (18:1, n-9) and stearic (18:0) acid contents. 
− Arachidonic-to-eicosapentaenoic acid ratio, as index of inflammation, was 
calculated as ratio between arachidonic acid (20:4, n-6) and eicosapentaenoic acid 
(20:5, n-3) membrane levels. 
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3.2. Human study protocols 
3.2.1. The PLANHAB study (experimental hypoxia and bed rest) 
This study is was conducted at the Olympic Sport Center Planica, in Rateče, Slovenia.  
Two floors of the Olympic center are structured to simulate any altitude conditions in 
the all areas and in each room individually. Eleven male young subjects (mean ± sem; 
age 24 ± 4 yr; BMI 22 ± 2 kg/m²) were selected to participate to the experimental study. 
The experimental protocol was approved by the ethical committee of the University of 
Ljubljana (Slovenia) and was in accordance with the Declaration of Helsinki and 
following amendments. A written informed consent was obtained from each 
individuals. Subjects were physically active before the study and none of them was 
under medication. 
Subjects have been randomly assigned to three groups. Each group participated to three 
experimental campaigns: i) 10-day normoxic normoxia (21 kPa oxygen) bed rest, NBR 
ii) 10-day hypoxic (12.5 kPa oxygen, corresponding to 4000 m above sea level) bed 
rest, HBR iii) 10-day hypoxic ambulation HAMB. Each campaign was preceded by 5 
days of dietary and environmental adaptation and was followed by 5 days of recovery 
(Figure 17). A 2-month wash-out period was allowed between each campaign. Dietary 
intake was controlled to maintain subjects in eucaloric condition; before the study, 
individual resting energy expenditure (REE) was calculated according to the 
FAO/WHO equations (Muller MJ et al. 2004).  
Each subject received a dietary energy intake equals to 1.4 and 1.1 times his REE in the 
ambulatory (adaptation and recovery periods as well as hypoxic ambulation) and bed 
rest (normoxic and hypoxic bed rests) periods, respectively. Menu composition was 
adapted to individual dietary habits. Subjects received six meals daily (i.e., 3 main 
meals and 3 snacks). Each individual was tested at the baseline (normoxic ambulation) 
and at the end (day 10) of each experimental condition. All foods were weighed for 
each participant, and volunteers were asked to consume the complete meal. At the 
beginning and at the end of each experimental condition, body composition was 
assessed by DXA (Discovery W—QDr series, Hologic, Bedford USA). Whole body 
protein turnover as well as glutathione kinetics were determined by stable isotope 
infusion technique, as previously described (see experimental design section 2.1.1, 
2.2.5). 
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Statistics 
All data were expressed as mean ± S.E.M. Hypoxia and bed rest effects were analyzed 
by repeated measure ANOVA with two levels of interaction, physical activity and 
oxygen partial pressure. If significant interaction was evidenced, post hoc analysis was 
performed using Student t-test with Bonferroni correction. Statistical significance was 
achieved with p-value <0.05. Statistical analysis was performed using SPSS software 
(version 12; SPSS, Inc., Chicago, IL). 
 
 
Figure 17. The PLANHHAB Study experimental design 
Subjects were randomly assigned to three groups. Each group participated to three experimental campaigns: i) 10-day normoxic 
normoxia  bed rest (yellow) ii) 10-day hypoxic bed rest (red) iii) 10-day hypoxic ambulation (blue). A 2-month wash-out period was 
allowed between each campaign. 
  
METHODS
• BODY COMPOSITION: DXA
• WHOLE-BODY PROTEIN KINETICS                   
Phe/Tyr stable isotope infusion in the 
postabsorptive state
10-d BED REST IN NORMOXIC CONDITION (n=11)
21 kPa oxygen
10-d BED REST IN HYPOXIC CONDITION (n=11)
12.5 kPa oxygen
10-d NORMAL PHYSICAL ACTIVITY IN HYPOXIC CONDITION (n=11)
12.5 kPa oxygen
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3.2.2. The PANGeA study (bed rest in the elderly) 
PANGeA is an European program (INTERREG) aiming to answer to some scientific 
questions that refer to the impact of motor inactivity on the elderly and, consequently, 
on their health. 
The bed rest study was conducted at the Valdoltra Hospital (University of Primorska, 
Ankaran-Capodistria, Slovenia). Fifteen healthy male subjects were enrolled: 7 young 
males (mean ± S.E.M.; age 23±1 years; BMI 24.0±0.9 kg/m2) and 8 elderly subjects 
(mean ± S.E.M.; age 59±1 years; BMI 26.8±1.5 kg/m2). Body weight of all subjects had 
been stable from the previous 3 months. Preliminary standard anthropometric measures 
and routine medical screening were performed. Volunteers were admitted at the hospital 
one week before the bed rest period for dietary and environmental adaptation phase 
(Ambulatory period). At the end of this period, each subject underwent 14 days of bed 
rest in which all daily activities were performed in horizontal conditions. 
The experimental protocol was approved by the ethical committee of the University of 
Ljubljana (Slovenia) and was in accordance with the Declaration of Helsinki and 
following amendments. A written informed consent was obtained from each persons. 
Subjects were physically active before the study and none of them was under 
medication, or had any acute or chronic illness at least from the three months preceding 
the protocol.  
Dietary intake was controlled to maintain subjects in eucaloric condition; before the 
study, individual resting energy expenditure (REE) was calculated according to the 
FAO/WHO equations (Muller MJ et al. 2004). Participants received a diet containing 
1.4 and 1.1 times their calculated REE during the ambulatory and the bed rest periods, 
respectively; All foods were weighed for each participant, and volunteers were asked to 
consume the complete meal. 
Menu composition was adapted to individual dietary habits. Subjects received three 
meals daily (i.e., breakfast, lunch and dinner). Each individual was tested at the baseline 
(BR0) and at the end (BR+14) of the experimental condition. In these days all subjects 
underwent to a metabolic test in order to estimate both insulin sensitivity and anabolic 
sensitivity in fed state through a new, simple, safe and quick method, as previously 
described (see experimental design section - 2.2.2, 2.2.3) 
At the beginning and at the end of each experimental condition, body composition was 
assessed by bioimpedentiometry (BIA 101, Akern Srl, Italy, following manufacture 
instructions) (Figure 18). 
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Statistics 
Data are expressed as mean ± SEM. In order to evaluate the effect of the bed rest and/or 
the effects of aging on the insulin resistance and on the anabolic resistance, multivariate 
ANCOVA statistical analysis was applied. Basal values were used as covariate. the 
changes induced by bed rest and/or aging, were assessed through a Student T-test. 
Linear regression analyses were performed using Pearson’s correlation. Data were 
logarithmic transformed when appropriate. P-values <0.05 were considered statistically 
significant. Statistical analysis was performed using SPSS software (version 12; SPSS, 
Inc., Chicago, IL). 
 
 
Figure 18. The PANGeA Study experimental design. 
During each experimental day (BR0 and BR+14), after basal blood sampling, at time 0 (t0), an oral load of 0.3g of 2H5-
phenylalanine, dissolved in 15-20mL of water, was administred to the volunteers to be drank in 5 minutes. Blood samples were 
drawn at 30, 60, 120, 180, 240, 300 and 360 minutes after the the loading. 
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4. RESULTS 
4.1. The PLANHAB study (experimental hypoxia and bed rest). 
4.1.1. Body composition 
As reported elsewhere (Debevec T. et al. 2014) there was a significant reduction in 
body weight in all 3 conditions (–2.1%, –2.8%, and –2.0% for HAMB, HBR, and NBR, 
respectively; p<0.05), due to a significant decrease in lean body mass (–3.8%, –3.8%, –
4.3% for HAMB, HBR, and NBR, respectively; figure 19A) with a slight but not 
significant increase in fat mass (Figure 19B). 
 
Figure 19. Effect of hypoxia in ambulatory conditions and during 10-d of bed rest 
on body composition. 
N=11. Body composition changes before (basal, white columns) and after (intervention, black columns) ambulatory hypoxia 
(HAMB), bed rest Hypoxia (HBR) and bed rest normoxia (NBR) conditions * for p<0.05. 
 
4.1.2. Whole body protein kinetics  
As showed on table 3 Hypoxia significantly decreased whole body protein turnover 
(protein synthesis, -8±3%; protein degradation, -9±3%) in ambulatory conditions, while 
hypoxia tended to increase the rates of synthesis (+4±4%) and degradation (+2±4%) in 
bed rest. There were not significant effects of hypoxia or bed rest on the rates of 
phenylalanine hydroxylation to tyrosine (Figure 18), an index of net protein loss in the 
postabsorptive state (Basal 0.12±0.01, HAMB 0.11±0.01, NBR 0.12±0.01, HBR 
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0.11±0.01 mmol/min/kg LBM; bed rest effect p=0.98, hypoxia effect p=0.08, 
interaction 0.66).  
 
Table 3 Effects of 10-d bed rest and hypoxia, per se or in combination, on protein 
metabolism. 
 Ambulatory Bed Rest p# 
 Control Hypoxia Control Hypoxia Bed rest effect 
Hypoxia 
effect Interaction 
Rd to protein synthesis 
(mmol/min/kg LBM) 0.96±0.03 0.88±0.03* 0.92±0.02 0.95±0.03 0.86 0.57 0.001 
Ra from proteolysis  
(mmol/min/kg LBM) 1.08±0.03 0.99±0.04* 1.04±0.02 1.06±0.03 0.91 0.36 0.001 
Rd to hydroxylation 
(mmol/min/kg LBM) 0.12±0.01 0.11±0.01 0.12±0.01 0.11±0.01 0.98 0.08 0.66 
N=11. Data were expressed as mean±S.E.M. # Data were analyzed with the use of a 2-factor repeated measure ANOVA. Rd, rate of 
disappearance. Ra, rate of appearance. * p<0.05 
On figure 20 are shown the effects of hypoxia and bed rest, alone or in combination, on 
the rates of whole body protein synthesis and degradation. There was significant 
hypoxia×bed rest interaction for the rates of protein synthesis and degradation.  
 
 
Figure 20. Effect of hypoxia in ambulatory conditions and during 10-d of bed rest 
on whole body protein kinetics. 
N=11. Whole body protein kinetics changes in ambulatory and bed rest states during hypoxia (white columns), or normoxia (black 
columns) conditions * for p<0.05. 
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No changes were observed on phenylalanine hydroxylation an index of net protein loss 
(Figure 21). 
 
 
Figure 21. Effect of hypoxia in ambulatory conditions and during 10-d of bed rest 
on phenylalanine hydroxylation. 
N=11. phenylalanine hydroxylation changes in ambulatory and bed rest states during hypoxia (white columns), or normoxia (black 
columns) conditions * for p<0.05. ns = non significant  
 
  
0
0.05
0.1
0.15
0.2
Ambulatory
Normoxia Hypoxia
Bed rest
PHENYLALANINE HYDROXYLATION
µm
ol
/k
g/
m
in
ns ns
 64 
4.1.3. Plasma lipid profile 
Effects of hypoxia per se and/or combined to bed rest lipid profile are reported on table 
4.  
 
Table 4. Effects of 10-d bed rest and hypoxia, per se or in combination on plasma 
lipid profile. 
 
Ambulatory Bed Rest p# 
Normoxia Hypoxia Normoxia Hypoxia 
Bed rest 
effect 
Hypoxia 
effect 
Interaction 
PLASMA LIPIDS 
Total cholesterol (mg·dL-1) 184±13 173±8 174±10 180±11 0.66 0.67 0.12 
Tryglicerides (mg·dL-1) 94±14 113±14* 109±20 102±13 0.65 0.38 0.02 
HDL cholesterol (mg·dL-1) 49±3 41±2* 42±2 39±3 <0.01 <0.001 0.02 
LDL cholesterol (mg·dL-1) 117±12 110±7 110±7 121±9 0.57 0.70 0.14 
HDL2-to-HDL3 ratio 0.48±0.08 0.43±0.07 0.55±0.09 0.38±0.05 0.93 0.26 0.55 
ENZYMES INVOLVED IN LIPID METABOLISM 
Cholesteryl ester transfer 
protein (µg·mL-1) 
2.91±0.23 3.00±0.16 2.86±0.20 3.01±0.19 0.87 0.31 0.85 
Lecithin-cholesterol 
acyltransferase (ng·L-1) 
21.8±4.2 20.3±4.3 21.7±4.7 23.8±6.3 0.66 0.99 0.45 
Lipoprotein lipase (ng·L-1) 28.4±3.3 23.9±3.6 27.5±4.0 26.8±3.7 0.48 0.28 0.43 
Hepatic lipase (U·mL-1) 0.72±0.10 0.79±0.09 0.80±0.09 0.90±0.08 0.15 0.04 0.81 
N=11. Data were expressed as mean±S.E.M. # Data were analyzed with the use of a 2-factor repeated measure ANOVA. *p<0.05 
HDL concentrations were significantly decreased both by bed rest and hypoxia with a 
significant negative bed rest×hypoxia interaction (Figure 20).  
Furthermore the ratio between HDL and total cholesterol (Figure 20) was significantly 
decreased by physical inactivity (-8±4%, p=0.001) and hypoxia (-11±4%, p=0.003).  
The ratio between HDL2 and HDL3 were not significantly changed. Plasma levels of 
total cholesterol, LDL and triglycerides were not significantly affected by 10-d of bed 
rest with or without hypoxia. On the other hand, the exposure to hypoxia in ambulatory 
conditions increased the triglycerides concentrations without changes in the other 
plasma lipid fractions (Figure 22). 
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Figure 22. Effect of hypoxia in ambulatory conditions and during 10-d of bed rest 
on total and HDL cholesterol. 
N=11. HDL cholesterol (A), Total Cholesterol (B) and HDL-to-total cholesterol ratio (C) modifications in ambulatory and bed rest 
states during hypoxia (black columns), or normoxia (white columns) conditions. Data were analyzed with the use of a 2-factor 
repeated measure ANOVA. Significance for p<0.05. 
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Among the enzymes involved in lipid metabolism only HL was modified, with a 
significant increase in hypoxic conditions, together with a decreased LPL-to-HL ratio 
(p=0.05), independently from the physical activity levels (Figure 23). 
 
 
Figure 23. Effect of hypoxia in ambulatory conditions and during 10-d of bed rest 
on enzymes involved in lipid metabolism. 
N=11. LPL-to-HL ratio modifications in ambulatory and bed rest states during hypoxia (black columns), or normoxia (white 
columns) conditions. Data were analyzed with the use of a 2-factor repeated measure ANOVA. Significance for p<0.05. LPL, 
Lipoprotein lipase. HL, Hepatic Lipase. 
4.1.4. Insulin sensitivity. 
There were no significant effects of hypoxia or bed rest on plasma glucose and insulin 
concentrations or on HOMA-IR index (Table 5). However the Δ-5 desaturase index was 
significantly reduced by both exposure to bed rest (p=0.03) and hypoxia (p=0.02). The 
index decreased by 5±2% after 10 days of physical inactivity and by 6±2% after 10 days 
of hypoxia, as compared to baseline conditions (Figure 24). A bed rest×hypoxia 
interaction was not observed (p=0.15). 
 
Table 5. Effects of 10-d bed rest and hypoxia, per se or in combination, on glucose 
metabolism. 
 Ambulatory Bed Rest p# 
INSULIN SENSITIVITY Normoxia Hypoxia Normoxia Hypoxia 
Bed rest 
effect 
Hypoxia 
effect 
Interaction 
Fasting insulin (µU·mL-1) 7±1 7±1 7±1 6±1 0.85 0.93 0.27 
Fasting glucose (mg·dL-1) 94±2 93±1 93±1 92±1 0.35 0.57 1.00 
HOMA index 1.5±0.2 1.7±0.2 1.6±0.2 1.5±0.1 0.74 0.98 0.29 
N=11. Data were expressed as mean±S.E.M. # Data were analyzed with the use of a 2-factor repeated measure ANOVA. *p<0.05 
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Figure 24. Effect of hypoxia in ambulatory conditions and during 10-d of bed rest 
on the activity of Δ-5 desaturase enzyme. 
N=11. Δ-5 desaturase activity modifications in ambulatory and bed rest states during hypoxia (black columns), or normoxia (white 
columns) conditions. Data were analyzed with the use of a 2-factor repeated measure ANOVA. Significance for p<0.05.  
Tumor necrosis factor Related Apoptosis Induce Ligand (TRAIL)  
Plasma TRAIL concentration was significantly increased by hypoxia (+36±6%, 
p=0.001) and a significant bed rest×hypoxia interaction was reported (p=0.04). A 
significant direct correlation between TRAIL and GSH-to-GSSG ratio was observed, as 
reported in figure 25. 
 
 
Figure 25. Correlation between TRAIL and GSH-to-GSSG ratio. 
N=11. TRAIL and GSH-to-GSSG ratio positive relationship in hypoxic bed rest conditions. Significance for p<0.05.  
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4.1.5. Inflammatory responses. 
Hypoxia, but not bed rest, significantly increased the levels of C reactive protein (CRP) 
and serum amyloid A (SAA) indices of systemic inflammation, without a significant 
bed rest×hypoxia interaction (Figure 26). 
 
 
Figure 26. Effect of hypoxia in ambulatory conditions and during 10-d of bed rest 
on the activity of inflammatory status. 
N=11. SAA (A) and PCR (B) modifications in ambulatory and bed rest states during hypoxia (black columns), or normoxia (white 
columns) conditions. Data were analyzed with the use of a 2-factor repeated measure ANOVA. Significance for p<0.05. SAA, 
serum amyloid A. CRP, C reactive protein. 
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4.1.6. Oxidative stress 
Glutathione redox capacity 
Data are reported on table 6. Hypoxia conditions significantly increased the hematocrit 
values (Figure 27). Thus, the results of glutathione concentrations and glutathione 
absolute turnover rate (ATR) were normalized by whole blood volume, taking into 
account the hypoxia-induced hematocrit changes, and also by erythrocyte volume. 
 
Table 6. Effects of 10-d bed rest and hypoxia, per se or in combination, on 
glutathione redox capacity in erytrocytes (RBC) and in whole blood (WB). 
 Ambulatory Bed Rest p# 
 Normoxia Hypoxia Normoxia Hypoxia 
Bed rest 
effect 
Hypoxia 
effect 
Interaction 
Hematocrit (%) 46±1 51±1 47±1 51±1 0.07 0.03 0.10 
Total glutathione 
(mmol/L RBC) 
2692±84 2620±79 2564±85 2547±86 0.03 0.22 0.42 
Glutathione ATR 
(mmol/day/L RBC) 
656±135 858±88 869±82 1250±263 0.05 0.06 0.53 
Total glutathione 
(mmol/L WB) 
1245±49 1332±51 1207±37 1302±45 0.21 <0.001 0.82 
Glutathione ATR 
(mmol/day/L WB) 
299±61 430±44 409±38 637±134 0.04 0.03 0.49 
Glutathione FTR 
(percent/day) 
25±5 33±3 35±4 50±10 0.04 0.05 0.58 
GSH/GSSG (ratio) 137±26 237±43* 221±37 176±36 0.81 0.40 0.009 
N=11. Data were expressed as mean±S.E.M. # Data were analyzed with the use of a 2-factor repeated measure ANOVA. ATR, 
absolute turnover rate. FTR, fractional turnover rate. GSH/GSSG, ratio between reduced and oxidised glutathione. RBC, red blood 
cell. WB, whole blood. Significance for p<0.05. 
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Figure 27. Effect of hypoxia in ambulatory conditions and during 10-d of bed rest 
on Hematocrit. 
N=11. Hematocrit modifications in ambulatory and bed rest states during hypoxia (black columns), or normoxia (white columns) 
conditions. Data were analyzed with the use of a 2-factor repeated measure ANOVA. Significance for p<0.05.  
Total glutathione concentrations normalized by erythrocytes volume significantly 
decreased following bed rest in both normoxic or hypoxic conditions, with no 
significant bed rest×hypoxia interaction (Figure 28A). 
  
 
Figure 28. Effect of hypoxia in ambulatory conditions and during 10-d of bed rest 
on glutathione metabolism in erythrocytes. 
N=11. Total glutathione concentration (A) and Glutathione Absolute synthesis rate (B) modifications in red blood cells during 
ambulatory and bed rest states in hypoxia (black columns), or normoxia (white columns) conditions. Data were analyzed with the 
use of a 2-factor repeated measure ANOVA. Significance for p<0.05. GSH, glutathione. ATR, absolute synthesis rate. RBC, red 
blood cell. 
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The glutathione ATR normalized by RBC volume, shows a significant increase 
following 10-d of immobilization in both normoxic and hypoxic states (Figure 28B).  
The total glutathione concentration normalized by whole blood volume shows a 
significant positive effect of hypoxia in both ambulatory and BR conditions (Figure 
29A). The glutathione ATR normalized by whole blood volume shows an increased 
turnover rate influenced both by hypoxia and physical inactivity (Figure 29B).  
The GSH/GSSG ratio, an index of the redox balance, indicates a significant 
hypoxia×bed rest interaction on the ratio. Hypoxia and BR conditions significantly 
increased the glutathione FTR (Figure 29C). 
 
 
Figure 29. Effect of hypoxia in ambulatory conditions and during 10-d of bed rest 
on glutathione metabolism in whole blood. 
N=11. Total glutathione concentration (A) and Glutathione Absolute synthesis rate (B) modifications in whole blood and 
glutathione fractional synthesis rate (C) changes, measured during ambulatory and bed rest states in hypoxia (black columns), or 
normoxia (white columns) conditions. Data were analyzed with the use of a 2-factor repeated measure ANOVA. Significance for 
p<0.05. GSH, glutathione. ATR, absolute synthesis rate. FTR fractional synthesis rate. WB, whole blood. 
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4.1.7. Plasma and erythrocyte GSH amino acid precursor 
Plasma concentrations of glutamate and cysteine were increased due to hypoxia, for 
glycine plasma levels there is a bed rest×hypoxia interaction. In erythrocytes, hypoxia 
induced a statistically significant increase in glycine concentrations while no effects 
were observed on the concentrations of the other glutathione amino acid precursor 
(Table 7). Hypoxia inversely affected plasma concentrations of glutamate and 
glutamine. Glutamine decreased by about 4%, while glutamate increased by about 12%, 
both in ambulatory and bed rest conditions. There was a significant hypoxia-induced 
increase (+19±6%, p<0.01) on the glutamate-to-glutamine ratio. The 5-oxoproline 
plasma concentrations tended to decrease in hypoxic condition both in ambulatory and 
bed rest states  
 
Table 7. Effects of 10-d bed rest and hypoxia, per se or in combination, on amino 
acid concentrations in plasma and red blood cells. 
 Ambulatory Bed Rest p# 
 Normoxia Hypoxia Normoxia Hypoxia 
Bed rest 
effect 
Hypoxia 
effect 
Interaction 
PLASMA AMINO ACID CONCENTRATIONS 
Cysteine (µmol×L-1) 294±12 299±11 277±10 304±11 0.45 0.005 0.27 
Glycine (µmol×L-1) 172±9 185±10* 196±12 185±12 0.04 0.78 0.01 
Glutamate (µmol×L-1) 61±4 69±5 62±3 67±3 0.81 0.03 0.59 
Glutamine (µmol×L-1) 541±10 515±9 552±21 522±7 0.55 0.01 0.86 
Homocysteine (µmol×L-1) 15.3±1.7 17.0±1.4 14.7±1.4 16.2±1.4 0.38 0.003 0.93 
5-oxoprolinea (µmol×L-1)a 1.01±0.08 0.91±0.06 1.00±0.07 0.91±0.06 0.92 0.08 0.90 
ERYTHROCYTE AMINO ACID CONCENTRATIONS 
Cysteine (µmol×L-1) 70±3 79±3 72±4 70±3 0.20 0.33 0.07 
Glycine (µmol×L-1) 368±11 389±13 372±12 393±12 0.49 <0.001 0.98 
Glutamate (µmol×L-1) 477±24 481±18 448±16 478±17 0.33 0.16 0.37 
Glutamine (µmol×L-1) 1053±147 1015±209 1042±141 1000±215 0.79 0.73 0.97 
N=11. Data were expressed as mean±S.E.M. # Data were analyzed with the use of a 2-factor repeated measure ANOVA. a, 5-
oxoproline concentrations have been estimated as ratio between 5-oxoproline and glutamate. Significance for p<0.05. 
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4.1.8. Red blood cell membrane lipid composition. 
Data on lipid composition in RBC membranes are reported in Table 8. There are no 
changes in FAs concentrations in any of the study protocols.  
 
Table 8. Effects of 10-d bed rest and hypoxia, per se or in combination on fatty 
acids composition (%) of erythrocyte membranes. 
  
Ambulatory Bed Rest p# 
Normoxia Hypoxia Normoxia Hypoxia 
Bed 
rest Hypoxia Interaction 
effect effect 
SATURATED FATTY ACIDS 
Myristic 14:00 0.20 ± 0.024 0.31 ± 0.32 0.3 ± 0.025 0.25 ± 0.020 0.45 0.08 0.01 
Palmitic 16:00 20.61 ± 0.36 20.9 ± 0.31 20.62 ± 0.26 20.81 ± 0.29 0.71 0.15 0.76 
Stearic 18:00 18.54 ± 0.20 18.42 ± 0.08 18.64 ± 0.17 18.45 ± 0.14 0.58 0.27 9.64 
SUM 39.35 ± 0.45 39.63 ± 0.37 39.55 ± 0.32 39.52 ± 0.34       
MONOUNSATURATED FATTY ACIDS 
Palmitoleic 16:1 n7 0.25 ± 0.04 0.27 ± 0.04 0.28 ± 0.04 0.26 ± 0.03 0.72 1.0 0.26 
Oleic 18:1 n9 13.34 ± 0.33 12.87 ± 0.33 12.81 ± 0.28 12.94 ± 0.34 0.08 0.1 0.06 
Elaidic trans 18:1n-9 1.03 ± 0.04 1.02 ± 0.03 1.01 ± 0.05 1.05 ± 0.05 0.7 0.45 0.14 
Eicosenoic 20:1n-9 0.31 ± 0.01 0.3 ± 0.01 0.3 ± 0.01 0.31 ± 0.01 0.86 0.75 0.1 
SUM 14.92 ± 0.37 14.46 ± 0.34 14.39 ± 0.23 14.56 ± 0.37       
n-3 POLYUNSATURATED FATTY ACIDS 
α-Linolenic acid 18:3 
n3  0.04 ± 0.02 0.04 ± 0.02 0.05 ± 0.02 0.04 ± 0.02 ns ns ns 
Eicosapentaenoic acid 
20:5n-3  0.53 ± 0.04 0.58 ± 0.04 0.56 ± 0.03 0.54 ± 0.04 0.94 0.5 0.1 
Docosapentaenoic 
22:5n-3 2.50 ± 0.08 2.57 ± 0.10 2.55 ± 0.09 2.57 ± 0.09 0.43 0.02 0.41 
Docosahexaenoic acid 
22:6n-3 4.48 ± 0.23 4.69 ± 0.26 4.63 ± 0.25 4.80 ± 0.2 0.02 0.01 0.83 
SUM 7.50 ± 0.25 7.84 ± 0.30 7.74 ± 0.26 7.91 ± 0.19       
n-6 POLYUNSATURATED FATTY ACIDS 
Linoleic acid 18:2 n6  11.87 ± 0.35 11.72 ± 0.32 11.6 ± 0.35 11.39 ± 0.29 0.08 0.21 0.83 
Eicosadienoic acid 
20:2n-6 1.09 ± 0.51 1.47 ± 0.56 1.13 ± 0.19 0.89 ± 0.24 0.6 0.63 0.5 
Dihomo-γ-linolenic 
20:3n-6 1.97 ± 0.13 2.04 ± 0.13 2.08 ± 0.12 2.16 ± 0.13 0.001 0.02 0.98 
Arachidonic acid 
20:4n-6 18.11 ± 0.28 17.7 ± 0.27 18.16 ± 0.21 18.39 ± 0.32 0.04 0.49 0.02 
Adrenic 22:4n-6 4.15 ± 0.20 3.99 ± 0.18 4.12 ± 0.17 4.17 ± 0.18 0.07 0.02 0.02 
Docosapentaenoic 
22:5n-6 0.99 ± 0.08 1.10 ± 0.13 1.17 ± 0.17 0.98 ± 0.08 0.71 0.47 0.17 
SUM 38.22 ± 0.79 38.08 ± 0.72 38.31 ± 0.65 38.01 ± 0.64       
N=11. Values are percent of total Fatty Acids. Data were expressed as mean±S.E.M. # Data were analyzed with the use of a 2-factor 
repeated measure ANOVA Significance for p<0.05. 
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4.2. The PANGEA STUDY (bed rest in the elderly) 
4.2.1. Body composition 
Body composition was significantly modified after 14 days of BR both in young and 
elderly subjects. As showed in table 9, body weight and BMI significantly decrease 
after 14-d of resting with a reduction in FFM (Figure 30A) and a slight but significant 
increase in FM (Figure 30B). 
Table 9. Anthropometrical data before (BDC-1) and after (BR+14) bed rest in 
young and elderly subjects. 
    p# 
 subjects BDC-1 BR+14 Bed rest effect 
bed rest × 
group 
interaction 
Body weight 
(kg) 
Young 74.84 ± 3.32  71.59 ± 3.14 <0.001 0.08 Elderly 79.64 ± 3.71 77.58 ± 3.67 
BMI (kg/m2) Young 23.96 ± 0.89 22.91 ± 0.81 <0.001 0.12 Elderly 26.85 ± 1.47 26.15 ± 1.45 
FFM (kg) Young 60.86 ± 1.46 56.36 ± 1.43 <0.001 0.18 Elderly 59.79 ± 2.43 56.66 ± 2.41 
FM (kg) Young 13.99 ± 2.34 15.33 ± 2.66 0.01 0.74 Elderly 19.85 ± 1.75 20.91 ± 1.69 
N=7 young group; N=8 elderly gourp. Data were expressed as mean±S.E.M. #Data were analyzed with the use of a 2-factor 
repeated measure ANCOVA. BMI: Body Mass Index, FFM: Fat-Free Mass, FM: Fat Mass. 
 
Figure 30. Body composition modifications after 14-d of bed rest in young and 
elderly subjects. 
N=7 young group; N=8 elderly group. Body composition modifications in ambulatory conditions (black column) and after 14-d of 
bed rest (white column). in young and elderly subjects. Data were expressed as mean±S.E.M. Data were analyzed with the use of a 
2-factor repeated measure ANCOVA. FFM, Fat-free Mass. FM Fat Mass.  
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4.2.2. Insulin sensitivity. 
Glucose and insulin metabolism data, assessed in basal conditions and during load, 
before and after 14-d of experimental inactivity, are reported in table 10. The metabolic 
basal values were similar between the two groups. Plasma glucose concentration in 
fasting state were not significantly modified after 14-d of BR while the fasting insulin 
plasma concentration were augmented especially in young subjects (+74±21% and 
+16±12% in young and elderly individuals respectively).  
The HOMA-IR, as index of insulin resistance in fasting state, significantly increase 
after BR in both young and elderly subjects, however, young individuals shown 
significantly (p=0.04) higher values (+80±29%) than eldelry (+12±13%). 
 
Table 10. Glucose metabolism data before (BDC-1) and after (BR+14) bed rest in 
young and elderly subjects. 
     p# 
 subjects BDC-1 BR+14 
Delta % 
(BR+14 – 
BDC-1) 
Bed 
rest 
effect 
bed rest × 
group 
interaction 
Fasting glycaemia 
(mg/dL) 
Young 87 ± 4.30 86.57 ± 1.90 1.09 ± 5.74 0.45 0.54 
Elderly 96.38 ± 4.00 92.38 ± 2.39 3.29 ± 3.75 
Fasting insulinaemia 
(UI/L) 
Young 5.14 ± 1.10 8.43 ± 1.54 74.32 ± 21.06 <0.01 <0.05 
Elderly 5.25 ± 0.77 5.88 ± 0.90 15.63 ± 11.52 
HOMA index Young 1.11 ± 0.23 1.82 ± 0.35 79.67 ± 28.86 0.02 <0.05 
Elderly 1.27 ±0.20 1.34 ± 0.21 12.44 ± 12.72 
Matsuda index Young 26.93 ± 4.24 14.21 ± 2.38 -45.95 ± 4.51 <0.001 0.01 
Elderly 18.79 ± 1.50 14.95 ± 2.09 -20.34 ± 9.42 
AUCIns (UI h/L) Young 99.86 ± 17.47 207.68 ± 37.96 113.29 ± 19.12 <0.01 0.02 
Elderly 133.84 ± 12.97 198.38 ± 26.82 48.78 ± 14.24 
AUCGluc (mg h/dL) Young 311.61 ± 13.76 334.50 ± 13.82 7.84 ± 3.64 <0.05 0.94 
Elderly 372.13 ± 23.56 396.81 ± 24.47 7.58 ± 5.66 
AUCIns/AUCGluc Young 0.33 ± 0.06 0.62 ± 0.11 98.31 ± 17.22 0.001 0.02 
Elderly 0.37 ± 0.04 0.51 ± 0.07 38.93 ± 12.73 
N=7 young group; N=8 elderly gourp. Data were expressed as mean±S.E.M. #Data were analyzed with 2-factor repeated measure 
ANCOVA. data were logarithmic transformed when appropriate 
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Matsuda index, as parameter of insulin sensitivity in fed state (loading), showed a 
reduction due to the 14-d of BR (Figure 31) in both groups but it was doubled in young 
than in elderly (-46±5% vs -20±9%, respectively, p=0.04). 
 
Figure 31. Matsuda index modifications after 14-d of bed rest in young and elderly 
subjects. 
Interaction = bed rest × group interaction. Data analyzed with the 2-factor repeated measure ANCOVA 
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The area-under-the curve (AUC), i.e., the area under of both plasma glucose (AUCGly) 
and plasma insulin (AUCIns) concentrations during the test meal versus time, was 
estimated using the linear trapezoidal method. In basal condition the AUCIns values 
were comparable between the two groups while the AUCGly values were greater in 
elderly than in young people about of 19% (Figure 32B and D). After BR the AUCIns 
was augmented in both groups with a significant (p=0.02) higher increase in the young 
population (+113±19%) if compared to the elderly group (+49±14%). (Figure 32A and 
C). 
The AUCIns/AUCGly ratio, as index of insulin resistance after load, was augmented in 
both young and elderly subjects after bed rest however the young individuals showed a 
significant (p=0.01) higher increase of this value (+98±17%) than elderly population 
(+39±13%) (Table 9). 
 
 
Figure 32. Glycaemia and insulinaemia modifications before (◼ ︎) and after 14-d of 
bed rest () in young (A and B) and elderly (C and D) subjects. 
Interaction = bed rest × group interaction. Data analyzed with the 2-factor repeated measure ANCOVA 
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4.2.3. Anabolic resistance 
The plasma AA concentrations as well as the isotopic enrichment of D5-Phe and D4-
Tyr, before and after the bed rest period, were assessed by GCMS as previously 
reported (see methods section). 
To evaluate the effect of ageing and bed rest on anabolic resistance the AUC i.e., the 
area under of both plasma D5-Phe (AUCD5-Phe) and plasma D4-Tyr (AUCD4-Tyr) 
concentrations during the test meal versus time, were calculated. Moreover the AUCs of 
unlabeled phenylalanine (AUCPhe), tyrosine (AUCTyr) and leucine (AUCLeu) were also 
assessed (Table 11). 
As showed in table 10 AUCPhe significantly increased after 14-d of bed rest (4%) with 
no time×group interaction. No significant changes were observed after 14-d of 
experimental inactivity on AUCTyr and AUCLeu values. Leucine plasma concentrations 
are considered an index of the absorption of the amino acids from the protein 
administered with the teat meal. We observed that the leucine peak at 60 minutes was 
comparable between the ambulatory and bed rest conditions both in young and elderly 
subjects, showing no interference from the amino acid absorption rate. 
Table 11. Bed rest effect on labeled and unlabeled plasma amino acids 
concentration in young and elderly subjects 
  BDC-1 BR+14 
Delta % 
(BR+14 – 
BDC-1) 
p# 
Bed rest 
effect 
bed rest × 
group 
interaction 
AUC Phenylalanine Young 413.14 ± 27.58 430.49 ± 19.37 6.10 ± 5.93 0.03 0.60 
Elderly 401.27 ± 11.51 415.51 ± 16.13 3.61 ± 3.19 
AUC Tyrosine Young 516.02 ± 58.58 502.44 ± 44.51 0.47 ± 6.21 0.37 0.23 
Elderly 599.72 ± 44.09 614.95 ± 52.29 2.12 ± 2.92 
AUC Leucine Young 818.32 ± 41.91 815.92 ± 58.18 -0.31 ± 4.77 0.55 0.93 
Elderly 793.23 ± 43.15 798.06 ± 37.71 1.06 ± 2.64 
AUC D5-Phe Young 16.33 ± 1.67 16.44 ± 1.39 4.19 ± 9.41 0.14 0.54 
Elderly 16.13 ± 1.55 17.99 ± 2.29 13.24 ± 12.13 
AUC D4-Tyr Young 3.38 ± 0.60 3.30 ± 0.36 9.06 ± 14.06 <0.01 0.05 
Elderly 3.84 ± 0.43 4.93 ± 0.66 33.32 ± 15.78 
AUC D4-Tyr/ 
AUC D5-Phe 
(T0-T360) 
Young 0.20 ± 0.03 0.20 ± 0.01 5.20 ± 9.36 
<0.01 0.01 Elderly 
0.24 ± 0.02 0.28 ± 0.02 18.5 ± 7.27 
AUC D4-Tyr/ 
AUC D5-Phe (T120) 
Young 0.19 ± 0.02 0.19 ± 0.02 -0.53 ± 1.85 <0.05 <0.05 
Elderly 0.21 ± 0.02 0.27 ± 0.03 6.79 ± 3.85 
N=7 young group; N=8 elderly gourp. Data were expressed as mean±S.E.M. #Data were analyzed with 2-factor repeated measure 
ANCOVA. data were logarithmic transformed when appropriate. AUC, area under the curve.   
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On figure 33 were reported the D5-Phe and D4-Tyr plasma concentrations during the 
test meal before and after the BR period on both young and elderly subjects. 
 
 
Figure 33. D5-Phe and D4-Tyr plasma concentration before (◼ ︎) and after 14-d of 
bed rest () in young (A and B) and elderly (C and D) subjects. 
Interaction = bed rest × group interaction. Data analyzed with the 2-factor repeated measure ANCOVA 
 
No significant changes were observed on AUCD5-Phe after 14-d of experimental BR 
while the AUCD4-Tyr vales were significantly modified. 
In basal condition, the AUCD4-Tyr/AUCD5-Phe - T360 ratio, as index of anabolic resistance, 
was comparable between the two groups, after 14-d of BR. It appear increased in both 
young and elderly subjects, but with higher values in the elderly (+19±7%) than in the 
young (+5±9%) population, as confirmed by the significant time×group interaction 
(Table 10). 
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Figure 34. Bed rest effect on anabolic resistance expressed as AUCD4-Tyr/AUCD5-Phe 
ratio in young and elderly subjects 
Interaction = bed rest × group interaction. Data analyzed with the 2-factor repeated measure ANCOVA 
 
The AUCD4-Tyr/AUCD5-Phe - T360 ratio was evaluated considering all the blood draw 
points as reported in the experimental design (Figure 18). The same index was also 
calculated using the blood draw points of the first two hours of the experimental 
protocol (AUCD4-Tyr/AUCD5-Phe - T120). As reported on figure 34 (A and B) the AUCD4-
Tyr/AUCD5-Phe - T120 ratio showed the same trend observed with the AUCD4-Tyr/AUCD5-Phe 
- T360 ratio, moreover, a significantly direct correlation (R=0.75; p<0.001) was find 
comparing the two indices (Figure 35). 
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Figure 35. Correlation between the AUCD4-Tyr/AUCD5-Phe - T360 ratio and the 
AUCD4-Tyr/AUCD5-Phe - T120 ratio 
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5. DISCUSSION 
The primary aim of the present work was to develop biomarkers useful to define, in 
vivo, in humans, the optimal protein intake in different physiological and pathological 
conditions. Within the frame of two studies sponsored by the European Community 
(i.e., the FP7 PLANHAB Study and the INTERREG ITA-SLO PANGEA bed rest 
study), we applied such methodology to investigate protein requirement in conditions of 
inactivity, with or without hypoxia, as well as in a population of healthy elderly subjects 
assessed at different levels of physical activity, from ambulatory to bed rest. 
The assessment of whole body protein kinetics is a standard methodology to detect 
conditions of impaired protein synthesis and anabolic resistance, in the fasting state and 
stimulation by protein nutrition. We applied this method in the PLANHAB Study to 
investigate protein requirement in hypoxic condition both in ambulatory and bed rested 
individuals. The PANGeA study was the second study in the world where aged healthy 
people were bed ridden and the first one in which healthy elderly subjects were 
compared to healthy young individuals (as control group), during a period of 
experimental inactivity. Moreover it was the first time that both glucose and protein 
metabolism were assessed in healthy elderly volunteers undergoing bed rest. 
In the PANGEA study we developed a new method to assess the ability to utilize 
dietary protein during and after a mixed meal. Anabolic resistance is a condition 
characterized by reduced ability of meal protein to stimulate protein synthesis, thus 
increasing protein requirements. Our new method was used to compare anabolic 
resistance and protein requirement in elderly and young subjects either in ambulatory or 
in bed rest conditions.  
Moreover this new method allowed evaluate at the same time anabolic and insulin 
resistance in the post-prandial state. We had therefore the opportunity to explore the 
relationships between changes in insulin and anabolic resistance in elderly and young 
subjects at different levels of physical activity. The quantity of protein intake, not only 
influences the rate of protein synthesis but has an impact also on other metabolic 
targets, such as the redox balance. In particular the glutathione system is influenced by 
the availability of the precursor amino acids. We have therefore investigated different 
aspects of the glutathione system in the PLANHAB study with the aim to define the 
effects of hypoxia, with or without bed rest. 
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The relative proportion of cell membrane fatty acids was determined in the PLANHAB 
study in order to detect changes induced by insulin resistance or systemic inflammation 
and oxidative stress.  
 
The main results of our work can be summarized as follows: 
5.1. Hypoxia decreases protein synthesis. 
5.2. Aging is characterized by anabolic resistance. 
5.3. Aging is a protective factor against inactivity mediated insulin resistances? 
5.4. Hypoxia per se improves oxidative stress. 
5.5. Hypoxia-bed rest interaction induces multiple metabolic changes. 
5.6. Identification of a new biomarker to evaluate anabolic (and insulin) resistance 
to define optimal protein requirements. 
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5.1. Hypoxia decreases protein synthesis 
Chronic hypoxia and unloading are well-known protein catabolic factors for skeletal 
muscle (Biolo et al 2014; Di Giulio C et al. 2009). Ten days of normobaric hypoxia in 
ambulatory conditions or in horizontal bed rest in healthy volunteers led to similar 
losses of lean body mass. Bed rest in normoxic conditions led to a similar muscle 
catabolic response. Our study shows that when the two factors are applied in 
combination for 10 days in healthy volunteers they do not exhibit additive effects. The 
hypertrophic response of skeletal muscle trained in chronic hypoxia conditions was 
significantly lower than that produced in normoxia (Narici MV et al. 1995). Muscle loss 
associated with unloading is characterized by decreased protein turnover with a 
resistance to amino acid-mediated stimulation of protein synthesis as key catabolic 
mechanism. Protein synthesis is an energy consuming process. Hypoxia, which limits 
energy production, has been shown to decrease muscle protein synthesis (Preedy VR et 
al. 1985) in animal models, in vitro and in vivo. Decreased muscle protein synthesis has 
been observed also in emphysema patients with chronic respiratory failure (Morrison 
WL et al. 1988). In parallel with the rate of protein synthesis, hypoxia in ambulatory 
conditions also decreased by about 8% the rate of whole body protein degradation, 
leading to a decreased protein turnover.  
While normoxic subjects are characterized by accelerated post-exercise muscle protein 
turnover, in COPD patients with emphysema the rates of protein synthesis and 
degradation were suppressed after low-intensity exercise (Engelen MP et al. 2003). A 
blunted post-exercise suppression of muscle protein synthesis was also observed in 
experimental hypoxia (Etheridge T et al. 2011). Our results are in perfect agreement 
with these previous observations. Hypoxia in ambulatory conditions decreased by about 
8% the rates of whole body protein synthesis and degradation. In contrast, hypoxia in 
bed rest conditions did not significantly affect whole body protein turnover. As 
expected the net protein loss in the post-absorptive state was not accelerated by bed rest. 
In fact, post-prandial resistance to amino acid-mediated stimulation of protein synthesis 
is the key catabolic mechanism during muscle unloading. Net protein loss in the post-
absorptive state was not accelerated during hypoxia suggesting postprandial anabolic 
resistance also in this condition.  
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5.2. Aging is characterized by anabolic resistance 
During the PANGeA study we tested a new, simple, safe and quick method to evaluate 
the anabolic resistance to stimuli inducing protein synthesis (e.g. exercise, amino acids, 
etc.), associated with ageing. 
Our results confirm that both aging and physical inactivity impairs the sensitivity to 
anabolic stimuli (Kim IY et al. 2015; Biolo G et al. 2004). 
The development of anabolic resistance following physical inactivity was higher in the 
elderly than in the young subjects, evidencing that aging is a detrimental factor in the 
risk of an impaired inactivity-mediated protein metabolism. There is a potential decline 
in the efficiency of muscle protein synthesis with advancing age when a small amount 
of EEAs are ingested (Katsanos CS et al. 2005). Moreover, it was previously 
demonstrated (Biolo G et al. 2004) that decreased levels of physical activity in healthy 
young subjects were associated to compromise anabolic sensitivity to an amino acidic 
stimulus. After 14 days of experimental bed rest, in fact, a reduction in protein synthesis 
after AA administration was observed (Biolo G et al. 2004). Consequently, after a 
period of inactivity, it seems necessary to increase the protein intake in order to improve 
the protein anabolism in the fed state and overcome the anabolic resistance. The 
reduction of the sensibility of the muscle protein synthesis to an anabolic stimulus (i.e. 
protein intake and/or physical activity) associated with aging (Kim IY et al. 2015), leads 
to a reduction in muscle mass and strength, to an increased frailty with a higher risk of 
falls and generally to a higher morbidity and mortality (Breen L & Phillips SM. 2011). 
Moreover, this resulting loss of skeletal muscle protein could be a key factor in the 
development and the progression of sarcopenia and loss of function (Volpi E et al 
2000). 
Thus anabolic resistance is the principal catabolic mechanism responsible of muscle 
atrophy after a period of physical inactivity or during aging (Biolo G et al. 2004). The 
decreased ability to use AA for the MPS observed either with aging or in bed ridden 
young subject, seems to require an increased protein intake with the diet, especially 
when the two condition are associated. Furthermore, a larger intake of EAAs (i.e., 15 g 
in the form of beef) resulted in a similar stimulation of muscle protein synthesis (MPS), 
in young and old adults (Symons TB et al. 2007).  
However, a diet with high protein content could determine harmful effects in elderly 
subjects such as impairment of kidney function (Deutz NE et al. 2014). Nonetheless, a 
regular physical activity stimulates the MPS and contributes to maintain a positive 
protein balance, favoring the muscle mass gain both in young and elderly subjects 
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(Fiatarone MA et al.1990; Fiatarone MA et al. 1994). In healthy adults, both young and 
elderly, resistance and endurance exercise acutely stimulates muscle protein synthesis 
(Cuthbertson D et al. 2005; Short KR et al. 2004) and this effect is increased when 
physical activity is associated to protein administration (Breen L & Phillips SM. 2011). 
Our evidences suggest that during inactivity or aging there is an augmented protein 
need, and both exercise and proper nutrition could have intense effects on muscle mass 
and function. Therefore a correct lifestyle could counteract the consequences of aging. 
Specific nutritional programs can attenuate or even overcome the muscle loss associated 
to these conditions should be associated to specific training protocol. The hypothesis 
that an association of resistance training with higher protein intake from the diet or 
dietary supplements may have synergic effects has been confirmed in acute exercise 
conditions both in young and elderly subjects, (Biolo G et al. 1997; Rasmussen BB et 
al. 2006) 
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5.3. Aging is a protective factor against inactivity mediated insulin resistances? 
Aging can determine a progressive reduction of the tissues sensitivity to the insulin 
stimulation and therefore an impaired capability of the tissues to metabolize glucose 
(DeFronzo RA. 1981). The same detrimental effect is observed after a period of 
physical inactivity. Bed rest studies (Stuart CA et al. 1988) conducted on healthy young 
subjects showed that reduced insulin sensitivity develops soon after few days. 
Trained subjects show greater insulin sensitivity than individuals with a sedentary 
lifestyle. Both strength and resistance training improve insulin sensitivity and therefore 
glucose metabolism either in young or elderly subjects (Henriksen EJ. 2002), however 
if young individuals have an improved insulin sensitivity even after a single bout of 
exercise, in aged subjects more bout are required to observe the same effect (Henriksen 
EJ. 2002). These data seems to show that in healthy young trained persons the glucose 
level control is more efficient. Smorawiński J and his group have shown how, after 
three days of bed rest, both trained and untrained subjects exhibit a higher insulin 
resistance. Surprisingly the values of insulin resistance were grater in active than in the 
sedentary lifestyle subjects (Smorawiński J et al. 2000). These findings suggest that in 
trained subjects there is a faster compensatory response than in sedentary lifestyle 
individuals. 
The data observed in the PANGeA study confirm the findings of Smorawiński J and his 
group. The healthy young subjects, apparently more active than the elderly individuals, 
showed higher levels of insulin in fed state, after a period of 14-d of bed rest. The 
mechanisms of this peculiar insulin response require indeed further investigations. 
Probably aging determines a sort of adaptation to physical inactivity and consequently a 
higher resistance to alteration of the glucose metabolism. 
In ambulatory condition no insulin sensitivity changes were observed in both young and 
elderly groups, neither in fasting or fed state. 
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5.4. Hypoxia per se improves oxidative stress 
Glutathione is a critical factor in protecting cells against oxidative stress and in 
erythrocytes is critical for hemoglobin function (Dumaswala, UJ et al. 2001). In 
addition, erythrocyte glutathione contributes to the whole body redox equilibrium and is 
a marker of the glutathione status in other tissues, in particular in the liver (Biolo, G., et 
al. 2007). Glutathione redox capacity depends on the availability of total glutathione 
and by the ratio between reduced and oxidized glutathione (i.e., the GSH/GSSG ratio) 
(Biolo, G., et al. 2007). 
We have observed that hypoxia directly increased the hematocrit and total whole blood 
erythrocyte availability, while glutathione concentration per erythrocyte volume was not 
significantly changed. Such increase in total glutathione availability was associated with 
a parallel acceleration in the rate of glutathione turnover, expressed either as Fractional 
and Absolute Turnover Rate. 
The amino acid 5-oxoproline is an intermediate of the γ -glutamyl cycle and has been 
proposed as marker of glutathione status and turnover in cell systems and in animal 
models (Geenen S et al., 2013). In preliminary work we have tested the hypothesis that 
plasma 5-oxoproline level is a marker of in vivo glutathione synthesis and turnover in 
humans. We have developed a method to determine plasma 5-oxoproline levels in 
humans by stable isotopes, used as internal standard, and gas chromatography - mass 
spectrometry. The method has been validated in humans and first results have been 
published (Qi L et al. 2013). We have used the data obtained in the PLANHAB study to 
test the hypothesis that plasma 5-oxoproline levels could be suitable markers of 
glutathione turnover in red blood cells as determined by stable isotope infusions. The 
relationship between red blood cell glutathione synthesis rate and plasma 5-oxoproline 
levels, relative to the basal condition in healthy volunteers, are shown in figure 36. 
According to these results we are using plasma 5-oxoproline in conjunction with 
expression of the key enzyme for the glutathione synthesis glutamate cysteine ligase to 
assess glutathione synthesis capacity at the whole body level in the PLANHAB study.  
The 5-oxoproline in plasma tended to decrease suggesting an increased activity of the γ-
glutamyl cycle and glutathione turnover, not only in erythrocytes but also at the whole 
body level. Moreover the glutamate-to-glutamine ratio in plasma was increased in 
hypoxic conditions both in ambulatory and bed rest state, suggesting a higher disposal 
of this glutathione precursor. 
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Figure 36. Relationship between glutathione fractional synthesis rate in red blood 
cells and plasm 5-Oxoproline concentration, in healthy volunteers in the 
postprandial state. 
 
The hypoxia-mediated increase in glutathione turnover was accompanied by a rise in 
the plasma concentrations of precursor amino acids involved in the glutathione 
synthesis, i.e. glutamate and cysteine. Glycine plasma concentration is also increased by 
hypoxia but only in ambulatory conditions, however the erythrocyte concentration of 
this amino acid is increased by hypoxia in both ambulatory and bed rest condition. 
Hypoxia in ambulatory conditions also improved the GSH/GSSG ratio, suggesting a 
decreased production of reactive oxygen species (ROS). Moderate hypoxia is known to 
limit the excess production of ROS as well as reduce the oxidative damage to cells 
(Lopez-Barneo J et al. 2001). In contrast to the ambulatory condition, hypoxia in bed 
rest did not change significantly the GSH/GSSG ratio. Erythrocyte GSSG levels 
increased by about 100% following hypoxia in bed rest conditions, while it tended to 
decrease in ambulatory conditions. Evidence in vivo indicates that muscle unloading is 
characterized by oxidative stress and increased oxidized glutathione in skeletal muscle. 
We have recently shown that bed rest combined with overfeeding was associated with 
activation of erythrocyte glutathione system and markers of oxidative stress in plasma 
(Biolo, G. et al. 2008). In the present study, hypoxia enhanced glutathione redox 
capacity in either bed rest or ambulatory conditions. An increased hypoxia-mediated 
oxidative stress was demonstrated only in bed rest condition. 
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Plasma glutamine concentration. 
In our study, plasma glutamine concentrations decreased by about 4% following 
hypoxia. Glutamine depletion is often associated with stress conditions and systemic 
inflammatory response due to decreased muscle production and increased utilization by 
the immune system. Plasma glutamine concentrations have been found either normal or 
decreased in patients with COPD (Engelen MP et al. 2003). Pulmonary emphysema was 
associated with depletion of muscle glutamine (Engelen MP et al. 2000). Moreover, 
glutamine has been shown to upregulate glutathione recycling enzymes including 5-
oxoprolinase (Kaufmann Y et al. 2008). 
 
Tumor necrosis factor Related Apoptosis Induce Ligand (TRAIL) 
TRAIL is a member of the TNF-ligand family emerging as protecting factor against 
atherosclerosis (Volpato S. et al. 2011). As previously reported, TRAIL is inversely 
related to the risk of mortality in patients affected by cardiovascular disease (Biolo G. et 
al. 2012; Secchiero P. et al. 2009; Volpato S. et al. 2011). In moderately active subjects, 
in hypoxic conditions, we observed an increased TRAIL concentration that is directly 
correlated to changes in the ratio between GSH and GSSG. These data suggest that, in 
hypoxic condition, the anti-atherosclerosis properties of TRAIL are strictly related to 
hypoxia-induced increase in glutathione antioxidant defenses. The hypoxia mediated 
protective effects of TRAIL are completely blunted by exposure to physical inactivity. 
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5.5. Hypoxia-bed rest interaction induces multiple metabolic changes. 
Hypoxic diseases such as COPD and OSAS are associated with an accelerated 
atherogenesis and an increased cardiovascular morbidity and mortality (Schneider C et 
al., 2010; Ozkan Y et al., 2008). Hypoxic diseases are often associated with decreased 
physical activity till immobilization. Physical inactivity per se causes insulin resistance, 
dyslipidemia, hyperhomocysteinemia, flogosis and altered redox balance (Mazzucco S. 
et al., 2010; Biolo G. et al., 2005; Biolo G. et al., 2008). However, the separated and 
combined effects of hypoxia and/or inactivity on cardiovascular risk are not well 
defined (Drager L. F. et al., 2010; Taylor T. C. 2009). In the PLANHAB study we have 
investigated the net effects of normobaric hypoxia and/or physical inactivity, using the 
experimental model of bed rest, in healthy young volunteers. 
Considering the relevance of the protective effect of HDLs against atherosclerosis, the 
significant reduction in the plasma levels of these lipoproteins, observed after 10 days 
of normobaric hypoxia in all conditions (HBR, HAMB), can contribute to the increased 
cardio vascular risk of hypoxia, which worsens the negative effects of physical 
inactivity. This relation between hypoxia and decreased levels of HDLs was recently 
confirmed by extensive a meta-analysis (Nadeem R. et al. 2014). Other studies, 
however, have shown contrasting results (Wee J et al. 2013) possibly from 
inhomogeneous research protocols. 
In our study, hypoxia condition per se caused an increment of HL, a lipolytic enzyme 
synthesized and secreted by the liver, localized mostly at the surface of hepatic 
sinusoidal capillaries. HL is responsible for a faster hepatic HDL clearance, through 
various mechanisms, including the insulin resistance induced by both hypoxia and/or 
inactivity. The higher HL levels with a lower LPL/HL ratio correlated with the HDL 
plasmatic levels; HL and LPL being enzymes both involved in the clearance of these 
lipoproteins (Chatterjee C.& Sparks D. L. 2011; Annema W. & Tietge UJ. 2011; Blades 
B. et al., 1993). HL transforms HDL2 to smaller and denser HDL3 particles, which are 
probably cleared faster by the liver, causing a reduction of total HDL levels. In our 
study, the HDL2-to-HDL3 ratio did not significantly change suggesting an increased 
clearance of HDL3 possibly combined with a higher HDL3 formation from HDL2, 
from an enhanced HL activity. We may speculate that a higher HL concentration 
associated with reduced HDL plasma levels, may result in an increased atherosclerosis 
risk, through the of highly atherogenic, small, low-density-lipoproteins (LDL). Other 
enzymes, including LPL, LCAT and CETP can be involved in such alteration of lipid 
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metabolism (Mazzucco S. et al., 2010), nevertheless we did not observe changes in 
these enzyme levels, possibly because of the shorter protocol duration. 
Our data showed that triglyceride (TG) levels were increased in hypoxic ambulatory 
conditions, but not after bed rest. Different studies have shown an association between 
hypoxia, from high altitude exposure (Barnholt KE et al. 2006; Farias JG et al. 2006; 
Young PM et al. 1989) or respiratory clinical disorders (Sharma SK et al. 2011; Drager 
LF et al. 2010), and increased TG plasma concentrations. The mechanisms underling 
these changes, however, have not been completely defined (Adedayo AM et al. 2014; 
Jun JC et al. 2012).  
Inflammation plays a key role in the pathogenesis of many clinical conditions. Biolo G. 
et al. have previously reported an activation of systemic inflammation following 5 
weeks of physical inactivity, during bed rest (Biolo G. et al. 2008). Other studies 
(Siervo M et al. 2014; Regazzetti C. et al., 2008) have shown the role of hypoxic 
conditions on local and/or systemic inflammation. In our study short-term BR did not 
modify CRP and SAA levels but they were augmented in all hypoxic conditions. Our 
findings are consistent with reports showing that high altitude hypoxia stimulates the 
expression of pro-inflammatory markers, including CRP (Bailey DM et al. 2004; 
Hartmann G et al. 2000) and with studies on patients with severe OSAS, characterized 
by elevated SAA level. 
SAA is a HDL-associated apolipoprotein, which is considered an acute-phase factor 
during inflammation (Kotani K et al. 2013) and a biomarker of CVD and COPD (Korita 
I et al. 2013; Bozinovski S et al. 2008). SAA may act as pro-atherogenic agent inducing 
HDL dysfunction by apoA-1 displacement (Kotani K et al. 2013; Van Lenten B et al. 
2006; Yokoyama S et al 2006; Jahangiri A. et al. 2009; Tölle M et al. 2012; Alwaili K 
et al. 2012). Furthermore, SAA has been showed to affect cholesterol efflux from cells 
to HDL (Wroblewski J.M. et al. 2011). This could have contributed to the increased 
plasma HDL clearance leading to the decreased HDL plasma levels that we have 
observed. In our study the ratio between HDL and SAA was significantly reduced, more 
by hypoxia (-37±7%, p<0.01) than bed rest (-28±9%, p<0.01) suggesting that different 
mechanisms are involved in the combined effect of inactivity and hypoxia on HDL 
metabolism.  
Homocysteine plasma level is a well-recognized marker of atherosclerosis development 
(Glueck CJ et al. 1995; Baszczuk A et al. 2014), it might be responsible, alone, for 10% 
of heart failures, with a rising of this percentage to 90% when this marker is associated 
with other classic risk factors, including reduced HDL plasma levels (Baszczuk A et al. 
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2014). Lately, evidence (Nunomiya K et al. 2013; Kai S et al. 2006; Seemungal TA et 
al. 2007) indicates an involvement of homocysteinemia in the pathogenesis of COPD 
(Seemungal TA et al. 2007). Furthermore an association between CRP and 
homocysteine plasma levels was reported in these patients (Seemungal TA et al. 2007), 
suggesting a possible contribution of hyperhomocysteinemia to the development of the 
systemic inflammation. We reported a significant increase in homocysteine plasma 
levels due to hypoxia per se in all conditions. 
Activation of systemic inflammation is often observed during the development of 
insulin resistance. Ten days of bed rest and/or hypoxia did not significantly affected 
HOMA-IR index of insulin resistance (Blanc S. et al., 2000; Alibegovic A. C. et al., 
2010; Bergouignan A. et al., 2011; Bienso R. S. et al., 2012), however, we found a 
significant negative effect of both hypoxia and bed rest on the Δ5-desaturase activity 
index in erythrocyte membranes. As previously reported Δ-5 desaturase activity, can be 
considered a reliable marker of insulin sensitivity (Mazzucco S. et al., 2010). 
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5.6. Identification of a new biomarker to evaluate anabolic (and insulin) 
resistance to define optimal protein requirement. 
It is well documented that life expectancy in Europe is increasing. In the last years there 
has been a higher awareness of the metabolic alteration, associated to aging. The goal is 
to ensure a longer lifespan, together with an improved quality of life. Several metabolic 
pathologies are related to aging including: loss in muscle mass and strength (i.e. 
sarcopenia), T2DM, atherosclerosis and cardiovascular disease. These disorders are 
frequently associated to a reduced physical activity level, exercise being a key factor in 
the maintenance of the homeostasis of glucose and protein metabolism. Indeed, 
inactivity promotes the development of insulin resistance, T2DM and CVD, and can 
impair the muscle sensitivity to anabolic stimuli (e.g. amino acids, protein, etc.). On the 
contrary, higher levels of physical activity are associated with improved insulin 
sensitivity and enhanced protein synthesis in the fed state. Thus, both aging and 
physical inactivity have a negative impact on insulin and anabolic sensitivity. 
Moreover, because of the few available scientific evidences, one of the goals of the 
present work was to investigate the possible synergic effect of these two factors. 
The evaluation of “insulin resistance” and “anabolic resistance” requires complex and 
invasive techniques. The “gold standard” procedure for insulin sensitivity in human is 
the euglycemic-hyperinsulinemic clamp. This measurement consists in an infusion of 
insulin and glucose in the blood stream in order to evaluate the glucose uptake capacity 
of the tissues. Despite the extreme precision of this technique, the procedure is very 
invasive, time consuming and expansive, so it is frequently replaced by the oral glucose 
tolerance test (OGTT). This method, commonly used in clinical diagnosis, allows an 
evaluation of the glycaemia levels during and after a glucose load. The procedure 
however still remain invasive requiring at least 3 blood draws. Other methods utilize 
mathematical models that calculate insulin sensitivity in fasting or fed states (e.g. 
HOMA-IR index and Matsuda index, respectively). These models require few blood 
samplings (one for the fasting state evaluation and at least two for the after load 
measurements), are the easiest to aplly. 
To assess anabolic resistance and protein metabolism the most effective technique is the 
infusion in the blood stream of stable-labeled isotopes (tracers) and the measurement of 
the isotopic enrichment at the steady state. One the most used tracer in the assessment 
of the protein metabolism is the L-[ring-2H5]-phenylalanine (D5-Phe). After 
administration, D5-Phe is hydroxylated in [ring-2H4]-tyrosine (D4-Tyr), that represents 
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an index of net protein loss. For gold standard procedures this protocol has to be assess 
during an anabolic stimulus, such as amino acids infusion. 
Stable-labeled isotopes can be administered either orally or intravenously, but the latter 
way is the most used. The intravenous infusion protocol, however, is complex (it 
requires asepsis of the tracer solutions, two vein catheters etc.) and expansive and 
requires several blood samples, decreasing the compliance of the evaluated subjects. 
The oral administration protocol, on the other hand, consists in repeated intake of the 
tracer solution, at fixed period intervals. This is safer (just one vein catheter for the 
blood draws) and requires a simpler protocol (there is no need of an aseptic tracer 
solution). However, it still remains expansive, because of the quantity of stable-isotopes 
needed, and time consuming. 
With the above-mentioned techniques is not possible to assess “insulin resistance” and 
“anabolic resistance” at the same time or, at least, in the same experimental protocol. 
The present work proposes a new, simple, safe and quick method to evaluate 
simultaneously the “insulin resistance” and the “anabolic resistance” in fed state i.e. 
after a total meal (500 ml, 500 kcal, 55% carbohydrate, 15% protein, 30% fat) load with 
the administration of a single dose of tracer solution. This method was used to assess 
insulin and anabolic resistance after 14-d of bed rest in young and elderly subjects at 
different level of physical activity. The anabolic resistance was evaluated through a new 
index (i.e. AUCD4-Tyr/AUCD5-Phe -t120 ratio), proposed in this work for the first time, 
which needs a two hours duration procedure (instead of the 6h often required) and just 2 
blood draws versus the 7 samplings required in other protocols. This method does not 
allow to determine the protein kinetics (i.e. rate of synthesis and degradation) but it 
permits to calculate an important metabolic parameter, the anabolic sensitivity. The 
anabolic sensitivity, more than protein kinetics is an important index of the detrimental 
effect of aging or sedentary life style on muscle mass and protein metabolism. A safe, 
simple and quick method with limited cost is proposed. Moreover, as already said, this 
new method allows to evaluate simultaneously, and with the same procedure, anabolic 
and insulin resistance in post-prandial conditions, with an additional reduction in time 
and cost and with an improved compliance of the evaluated individuals. 
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6. CONCLUSIONS 
− Aging and bed rest are characterized by a higher protein requirement, 
confirming data from other studies. Anabolic resistance and insulin resistance are 
shared biomarkers of these conditions associated with skeletal muscle mass and 
function loss. However, the effect of inactivity on insulin resistance is blunted in aging.  
− We developed a new method to assess at the same time the two most relevant 
metabolic biomarkers (anabolic resistance and insulin resistance) of protein requirement 
in humans. 
− Other biomarkers related to these sarcopenic conditions are inflammation and 
redox balance.  
− Chronic exposure to experimental hypoxia decreases whole body protein 
synthesis in the post-absorptive state, suggesting an increased protein requirement also 
in this condition.   
− In addition, chronic hypoxia has a strong impact on cardiovascular risk markers 
(insulin resistance, homocysteine, systemic inflammation), often additive to that of 
inactivity (HDL-cholesterol). 
− Furthermore, hypoxia, in either ambulatory or bed rest conditions, significantly 
increased total glutathione concentrations and synthesis rate in erythrocytes. Hypoxia 
significantly increased redox glutathione capacity (i.e., GSH/GSSG ratio) in ambulatory 
conditions while this effect was blunted in bed rest. 
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